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Loss of cartilage due to trauma, tumour resection or congenital defects is a major challenge in 
craniofacial surgery [1]. Established methods for auricular reconstruction such as costal grafts 
are often accompanied by chest wall deformities or application of alloplastic implants causing 
foreign body sensation as well as bearing aesthetic deficits [2]. Thus, there is an increasing 
demand for satisfying alternatives. Tissue engineering holds the promise to enable the 
generation of autologous implants that likely meet the clinical need. The overall goal is to 
establish a procedure to obtain autologous cells by a method with minimal burden on the 
patient, after expansion seed the cells on custom-designed scaffold, differentiate or 
redifferentiate the cells applying growth factors and subsequently transplant the engineered 
cartilage construct. 
 
Cartilage Biology 
 
Understanding cartilage biology is inevitable for cartilage tissue engineering. Chondrocytes 
are embedded in extracellular matrix (ECM). Cartilage is not rich in cells, in human hyaline 
cartilage chondrocytes only represent 1% of the volume of hyaline cartilage thus cartilage 
ECM is of particular interest [3]. The interterritorial matrix is composed of a collagen 
network formed by collagen fibrils, which provides tensile strength and retains proteoglycans. 
Type II collagen represents the principle component of the macrofibrils. Type VI collagen 
forms the macrofibrils in the pericellular area and type IX collagen is crosslinked to the 
surface of the fibrils. Type X collagen is only synthesized by hypertrophic cells and is usually 
present only in calcified areas. Type XI collagen is another type of collagen, which can be 
found within the macrofibrils [4, 5]. Besides collagen proteoglycans are also responsible for 
cartilage characteristics. Their core is associated with one or more varieties of 
glycosaminoglycan chains. Glycosaminoglycans represent unbranched polysaccharides built 
of disaccharides. At least one disaccharide always bears a negative charge, which allows 
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interaction with water. The tissue fluid is another essential part of hyaline cartilage, because 
in exchange with the synovial fluid it provides nutrients and oxygen [3].  
Hyaline cartilage which is present in the joints and in the nose shows no fibres and has a 
glassy appearance. Besides hyaline cartilage, which is the most predominantly investigated 
type of cartilage, there are two other types. In comparison to hyaline cartilage fibrocartilage, 
which is localized at the end of the tendons and ligaments, has a higher content of collagen in 
the extracellular matrix, and in contrast to the other cartilage types, whose predominant 
collagen is type II, it also contains considerable amounts of type I collagen in addition to type 
II. Auricular cartilage is an elastic cartilage, which can also be found in the epiglottis. The 
ECM of this third type of cartilage also contains elastin in contrast to articular cartilage and 
fibrocartilage [3, 6–9]. Cartilage tissue engineering aims at a cartilaginous tissue mainly 
composed of the ECM described above, as the ECM determines the characteristics of the 
engineered cartilaginous tissue.  Expansion of chondrocytes in 2-dimensional (2D) 
environment, which is often necessary due to the limited number of harvestable cells, often is 
accompanied by dedifferentiation. Dedifferentiation causes changes in gene expression of 
type I and II collagen as well as of aggrecan. Consequently, often fibrocartilaginous tissue is 
formed, which is biochemically and biomechanically inferior compared to native cartilage 
[10, 11]. 
Chondrocytes are metabolically relatively inactive. Cartilage lacks innervation and vascular 
supply, nevertheless chondrocytes respond to mechanical stimuli, growth factors and 
cytokines influencing cartilage homeostasis [5]. The function of chondrocytes depends on 
their localization. Chondrocytes located in supporting tissue, as articular cartilage or nasal 
cartilage, synthesize and maintain ECM and therefore the tissue’s function. Chondrocytes are 
able to cope with conditions of low oxygen tension (ranging from 10% at the surface and 1% 
in deeper zones) as the majority of the energy required is obtained by glycolysis [8]. 
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After damage cartilage has a very low capacity of self-repair, as by being avascular, thus 
progenitor cells from blood or bone marrow have no access to the tissue [12]. Inherited, 
traumatic or degenerative cartilage defects demand engineered cartilage for repairing joint 
defects as well as for plastic reconstruction of the nose and the ear. 
 
Scaffolds for Cartilage Tissue Engineering 
 
Scaffolds are one of the key components of cartilage tissue engineering. A scaffold serves as 
cell carrier and may act simultaneously also as delivery system for proteins. It provides 
stability as well as the desired shape for the new tissue. The scaffold can not be reduced to 
being merely a mechanical support structure. It interacts with the cells, bioactive molecules 
and mechanical stimuli, which contribute to tissue generation and regeneration after 
implantation [13]. The desired, ideal scaffold is a 3-dimensional (3D) highly porous and 
interconnective construct, allowing for cell growth, nutrient supply and transport of metabolic 
waste. Moreover, it is supposed to be biocompatible and bioresorbable following controlled 
degradation. The chemistry of its surface should favour cell attachment, proliferation and 
differentiation. Another requirement is the mechanical stability which should fit the 
mechanical properties at the site of implantation [14]. 
A great variety of scaffold materials has been investigated for cartilage tissue engineering 
purposes [15]. The focus lay on polymeric scaffolds in form of hydrogels, sponges or meshes. 
Alginate, agarose, fibrin, collagen, chitosan, chondroitin sulphate, and gelatine are prominent 
examples for applied natural polymers. Natural polymers are often able to interact with cells, 
but are also capable of prompting an immune response. Inferior mechanical properties and 
variance in enzymatic degradation are other disadvantages of natural materials. In contrast to 
natural polymers, one advantage of synthetic materials is that they allow a design close to the 
mechanical requirements by physical and chemical modifications during synthesis [9]. Two 
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groups can be distinguished: degradable and non-degradable scaffolds. As the permanence of 
non-degradable materials is a great concern with regard to their long-term effects, a lot of 
efforts have been undertaken towards the development of degradable synthetic polymers for 
tissue engineering applications. For example, poly (lactic acid) (PLA), poly (glycolic acid) 
(PGA), as well as their copolymers poly (lactic-co-glycolic acid) (PLGA) are such materials 
approved by the Food and Drug Administration (FDA) [15]. 
 
Cell Sources for Cartilage Tissue Engineering 
 
To date several cell sources have been investigated for their application in regenerative 
medicine. Beside chondrocytes which represent the most obvious choice, mesenchymal stem 
cells (MSC) are in focus for cartilage tissue engineering purposes [13]. Chondrocytes have 
been isolated from articular, auricular, nasoseptal or costal cartilage, which are all capable of 
producing cartilaginous ECM [9]. All sources have in common that they do not render the 
necessary number of cells, thus making expansion necessary. Expansion of chondrocytes in 
2D environment is accompanied by rapid dedifferentiation [11] thus requiring 
redifferentiation, e.g., by the application of growth factors [13]. Undifferentiated progenitor 
cells possessing a multilineage potential would be a good alternative as they are easy to obtain 
and expand in vitro without loosing their ability to differentiate into various mesenchymal 
lineages [16]. MSC can be isolated from bone marrow (BMSC), adipose tissue (ASC), the 
synovial membrane or trabecular bone. Stem cells from bone marrow are the best 
characterized type of mesenchymal stem cells, although due to the risks and pain associated 
with their sampling procedure bone marrow may not be the ideal cell source for MSC. 
Adipose tissue would be an attractive alternative, as the access is easy, ASC are available in 
larger quantities and generally display a proliferation and differentiation potential comparable 
to that of BMSC [17]. However, with regard to cartilage engineering, it is still under 
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investigation of ASC can be stimulated to match the chondrogenic potential proven for 
BMSC [18–22]. 
 
Growth Factors for Cartilage Tissue Engineering 
 
Growth factors play a key role in cartilage tissue engineering, either with regard to improve 
tissue quality by triggering matrix production, increasing proliferation or in (re-) 
differentiation processes. They are inevitable for the differentiation of progenitors towards a 
chondrogenic phenotype. Redifferentiation of dedifferentiated chondrocytes after expansion 
also demands the application of growth factors. As proteins from the transforming growth 
factor-β (TGF-β) superfamily are key players during cartilage development they are also in 
the focus of the investigations concerning growth factor application in cartilage tissue 
engineering. TGF-β, BMPs, bFGF, and IGF-I have been investigated independently and 
simultaneously. Beside inducing differentiation and redifferentiation or improving construct 
quality by increasing matrix production growth factors can also be used to support 
proliferation of the cells [9]. 
 
Goals of the Thesis 
 
The goals of this work were defined in major parts defined by the project ‘Regenerative 
Implants’ which is a cooperation of several research groups from industry, hospitals and 
universities supported by a grant of the Bavarian Research Foundation (‘Bayerische 
Forschungsstiftung’) in the years 2006 to 2009. It comprised cartilage and bone tissue 
engineering as well as the generation of osteochondral constructs.  A subgroup of the research 
consortium including our department aimed at the generation of an ear-shaped cartilage 
construct and also participated in the generation of osteochondral constructs. 
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In order to obtain cartilage in the complex shape of the human external ear, a scaffold 
providing shape and stability for the growing tissue is required. In the preceding project 
‘FORTEPRO’ (also supported by grants of the Bavarian Research Foundation), a system 
combining the beneficial effects of soft and hard scaffolds had been established and the great 
benefits combining long-term stable fibrin gel [23] and polycaprolactone-based polyurethane 
(PU) scaffolds  had been shown [24].  Following these results, this system was to be 
transferred to polyurethane scaffolds in the complex shape of the external ear (Chapter 3 and 
4).  As an alternative system for auricular cartilage engineering oligo (poly (ethylene glycol) 
fumarate (OPF) scaffolds, produced in the department, were either alone or combined with 
long-term stable fibrin gel, investigated with regard to cartilage development (Chapter 5). 
Furthermore, the combination of long-term stable fibrin gel and polyurethane scaffolds was 
also applied aiming at osteochondral constructs (Chapter 6). 
The goal of attaining autologous cartilage constructs in clinically relevant size is associated 
with the challenge to provide a sufficient number of cells. As mentioned above (see ‘Cell 
Sources for Cartilage Tissue Engineering’), the most obvious cell source is cartilage from a 
non load-bearing area, from which autologous chondrocytes can be isolated. Due to the fact, 
however, that cartilage tissue is not rich in cells, the obtained chondrocytes have to be 
expanded in vitro. In turn, the rapid proliferation in 2-dimensional (2D) environment, e.g. 
culture flasks, is accompanied by rapid dedifferentiation [11], thus rendering a tissue rich in 
type I collagen, which is not desired for cartilage tissue engineering purposes. Thus, options 
for redifferentiation of dedifferentiated chondrocytes have to be established to obtain cartilage 
tissue employing expanded chondrocytes. Redifferentiation can be reached by application of 
growth factors. One part of this work dealt with the effect of the application of growth and 
differentiation factor-5 (GDF-5), a member of the BMP subfamily, either alone or in 
combination with insulin on cartilage construct quality using expanded chondrocytes (Chapter 
7). 
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A second possibility to yield a sufficient cell number is the use of mesenchymal stem cells. 
Mesenchymal stem cells from bone marrow are already well described and their multilineage 
potential has been proven, however, their application is associated with several disadvantages 
(see above). Another emerging cell source for mesenchymal stem cells is adipose tissue. It 
implies the advantage of a very good accessibility, is in most cases available in sufficient 
quantities and the multilineage potential of adipose tissue-derived stem cells (ASC) has also 
been shown [25, 26]. Thus, here it was investigated if the combination of GDF-5 and insulin 
similarly exerts similarly advantageous chondrogenic effects on ASC as seen for expanded 
chondrocytes (Chapter 7). Finally, in order to contribute to the clarification of the ongoing 
debate on the utility of the different stem cells, those publications in the literature were 
reviewed that directly compared BMSC and ASC within the same study with regard to their 
differentiation potential (Chapter 8). 
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Chondrocyte Isolation  
 
Bovine Chondrocytes 
Knee joints from 8-12 weeks old calves were obtained from a local abattoir (VION EGN, 
Vilshofen, Germany). Articular cartilage was attained from the surface of the femoral patellar 
groove. The isolated cartilage was cut into small pieces and kept in complete chondrocyte 
medium (CCM) in petri-dishes (Corning, Schiphol-Rijk, Netherlands) until the isolation of 
chondrocytes by enzymatic digestion with collagenase type II (Worthington, via Cell 
Systems, St. Katharinen Germany). Complete chondrocyte medium comprised the following 
constituents:  Dulbecco’s Modified Eagle’s Medium (DMEM) containing 4.5 g/l glucose, 584 
mg/l glutamine, 10% fetal bovine serum (FBS), 50 U/ml penicillin, 50 µg/ml streptomycin, 
10mM HEPES, 0.1 mM  non-essential amino acids (all from Gibco-Invitrogen, Karlsruhe, 
Germany), 0.4 mM proline (Sigma-Aldrich, Taufkirchen, Germany) and 50 µg/ml ascorbic 
acid (Sigma-Aldrich, Taufkirchen, Germany). The enzymatic digestion was conducted over 
night (17 hours) with collagenase type II followed by filtration through a 149 µm filter 
(Spectra Medical Industries via Novodirect, Kehl/Rhein, Germany). The filtrate was 
centrifuged (1200 rpm, 5 min) and washed three times with phosphate buffered saline (PBS) 
containing 50 U/ml penicillin and 50 µg/ml streptomycin (Gibco-Invitrogen, Karlsruhe, 
Germany) [27]. For determination of the cell number the obtained cell pellet was resuspended 
in CCM and counted with a hemocytometer and an inverted phase contrast microscope. 
 
Human Chondrocytes 
Primary human chondrocytes were isolated using sterile technique. Cartilage explants were 
obtained from patients (age of 20 – 55 years) undergoing nasal or auricular surgery after 
having given their consent (according to the approval of the local Ethics Committee, votum 
#05/169). Explants were cut into small pieces. After pre-digestion with pronase E (Sigma-
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Aldrich, Taufkirchen, Germany) digestion of the small pieces was conducted over night (17 
hours) with collagenase type II (Worthington, CellSystems, St.Katharinen, Germany). The 
digest was filtered through a 70 µm cell strainer (BD FalconTM via Schubert & Weiss 
OMNILAB GmbH & Co KG, München, Germany). After centrifugation at 1200 rpm for 5 
minutes the chondrocytes were washed three times with PBS containing containing 50 U/ml 
penicillin and 50 µg/ml streptomycin. Cell number was determined using a hemocytometer 
and an inverted phase microscope. 
 
Chondrocyte Expansion  
 
Bovine Chondrocytes (Chapter 5, 6) 
Primary chondrocytes were seeded in T150 cm2 culture flasks (7 500 cells/ cm2) (Corning, 
Schiphol-Rijk, Netherlands) and  in complete chondrocyte medium over 7 days in an 
incubator at 37° C, 95% humidity and 5% CO2. After reaching confluency the cells were 
washed with PBS and detached from the flask with trypsin 0.25% (Gibco-Invitrogen, 
Karlsruhe, Germany) (P1). After determination of the obtained cell number in passage 1 (P1), 
cells were again seeded in T150 cm2 culture flasks (7 500 cells/ cm2). After 4 days cells 
reached second confluency and were harvested by trypsinization as described above. 
 
Human Chondrocytes (Chapter 6) 
For the experiments with human passage 2 (P2) chondrocytes primary cells were seeded in 
T75 culture flasks at a density of 7500 cells per cm2 for expansion in 2D. After 12 days and 
reaching first confluency they were washed with PBS and trypsinized (trypsin 0.25% EDTA; 
Gibco-Invitrogen, Karlsruhe, Germany). In order to obtain passage 2 (P2) cells P1 
chondrocytes were seeded again in T75 culture flasks (5*105 cells per flask).  After further 7 
days cells were confluent and harvested for pellet culture. 
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In Vitro Cell Culture in 3D Environment 
 
Chondrocyte Culture on Polyurethane (PU) Scaffolds (Chapter 3) 
a) PU Discs 
Polycaprolactone-based polyurethane (PU) scaffolds were manufactured as previously 
described using a gas foaming process [28] and provided by polyMaterials AG (Kaufbeuren, 
Germany). If not stated otherwise, discs of 2 mm thickness with a diameter of 5 mm were 
punched out of the polyurethane scaffold (= routine discs). In order to increase the wettability 
of the PU scaffolds they were treated for 5 min with ethanol 70%. Afterwards ethanol was 
removed by rinsing the scaffolds five times with PBS. Subsequently the scaffolds were 
sterilized in PBS by autoclave sterilization. Under sterile conditions scaffolds were blotted to 
remove the fluid and placed in a 6-well plate for subsequent seeding with chondrocytes in 
long-term stable fibrin gel [23]. After first experiments, in which chondrocytes were 
suspended in the fibrinogen (Fibrinogen from bovine plasma, Sigma Aldrich, Taufkirchen, 
Germany) solution (100 mg/ml dissolved in Trasylol® (aprotinin solution, Bayer, 
Leverkusen, Germany), a separate study showed that concerning cartilage development there 
was no significant difference between starting with suspending the cells in the fibrinogen 
solution compared to suspending the chondrocytes in the thrombin solution. As the latter had 
distinct advantages during the seeding procedure, in the following, the chondrocytes were 
suspended in the thrombin solution (5 U/ml) (kind gift from Baxter, Germany) by adding 20 
µl of thrombin solution per 5*106 cells. Due to the volume of the chondrocytes, which was 
determined in a separate experiment, the resulting cell suspension had a concentration of 
1.25*105 chondrocytes per 1 µl suspension. 20 µl of this mixture were mixed with 20 µl of 
fibrinogen solution. The mixture was subsequently inserted into the scaffold disc in several 
portions using a 1ml syringe and a 20G needle (Braun, Melsungen, Germany). The resulting 
cell number per scaffold was 2.5*106 cells. After gel insertion the constructs were kept at   
37° C for 45 min in the incubator to allow gelation of the fibrin gel.  
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In order to evaluate the impact of the fibrin gel on cartilage development and on cell 
distribution, scaffold discs were also seeded with chondrocytes suspended in CCM. The 
expected initial number of cells per scaffold was 2.5*106 cells. The distribution of the cells in 
the PU scaffold disc was investigated at several time points (day 3, day 7, day 14 and day 21). 
Besides, the effect of gentle agitation (50 rpm) on the cell distribution was also analysed at 
several time points (d3, d7, d14 and d21). 
Then the scaffold discs were covered with 4 ml of CCM and cultured in an incubator at 37° C, 
95% humidity and 5% CO2 for 3 or 4 weeks respectively. Medium was replaced thrice a 
week. 
 
b) Ear-shaped PU Scaffolds  
The ear-shaped scaffold was treated before seeding as described above for the routine PU 
discs.  Then the ear-shaped scaffold was placed in a petri-dish and seeded with a nominal cell 
number of 250*106 chondrocytes in 2 ml of fibrin gel. Due to the rapid gelation of the fibrin 
gel, the gel was mixed and inserted in portions. After 45 min of gelation in the incubator at 
37° C the construct was transferred into a spinner-flask. The flask was filled with 120 ml 
CCM supplemented with 2.5 µg/ml insulin and stirred at a speed of 50 rpm during the culture 
period of 4 weeks in an incubator at 37° C, 95% humidity and 5% CO2. Medium was replaced 
thrice a week. After 28 days the ear-shaped cartilage construct was harvested. Prior to 
biochemical analysis respective samples were freeze-dried. 
 
Chondrocyte Culture on Oligo (poly) ethylene glycol) fumarate) (OPF) Scaffolds) (Chapter 5) 
a) OPF Discs 
OPF hydrogels, which are based on poly (ethylene glycol), were prepared as scaffolds [29] in 
our group using a gas foaming technique (M. Henke, manuscript in preparation). Three 
differently composed OPF hydrogel types were investigated. Foam 1 and foam 2 contained 
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NaHCO3 as foaming agent, whereas for foam 3 KHCO3 was chosen. Foam 1 contained only 
2.5% bisacrylamide, whereas foam 2 comprised 5% bisacrylamide as stabilizing agent, 
inhibiting rapid degradation. Foam 3 was stabilized by addition of poly (ethylene glycol) 
diacrylate.  After γ-irradiation sterile disc-shaped OPF scaffolds with a diameter of 
approximately 9 mm and a height of approximately 2 mm were placed in a 6-well plate. 200µl 
of a suspension containing 12.5*106 in CCM were gently dropped onto the scaffold disc. 
After 5 min of reconstitution of the OPF scaffold-hydrogels 7 ml of CCM were added and 
constructs were cultured in an incubator at 37° C, 95% humidity and 5% CO2 for 4 weeks 
respectively. In order to possibly enhance seeding efficiency as well as cell retention and 
mechanical stability during the culture period OPF hydrogels were additionally seeded with 
chondrocytes suspended in fibrin gel. In brief chondrocytes were suspended in thrombin 
solution (5 U/ml), 100 µl of the suspension containing 12.5*106 cells were mixed with 100 µl 
fibrinogen solution (100 mg/ml) and inserted into the scaffold. After leaving the constructs for 
45 min in the incubator (37° C, 95% humidity and 5% CO2) for gelation of the fibrin gel, 
discs were covered with 7 ml CCM. Constructs were cultured in an incubator at 37° C, 95% 
humidity and 5% CO2 for 4 weeks. 
 
b) Ear-shaped OPF scaffolds  
Ear-shaped OPF-scaffolds were prepared in our group according to the preparation of the 
OPF-discs but foamed in a custom-made silicone mold with the shape of the human external 
ear (Henke, M., manuscript in preparation). After γ-irradiation, ear-shaped OPF scaffolds 
were seeded with primary chondrocytes suspended in fibrin gel. 1 ml thrombin solution (5 
U/ml) containing 250*106 chondrocytes was mixed in portions with fibrinogen solution (100 
mg/ml). The construct was then placed in the incubator (37° C, 95% humidity and 5% CO2) 
for gelation of the fibrin gel for 45 min. The ear-shaped construct seeded with primary cells 
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was pre-cultured in a petri-dish (60 ml CCM) for 1 week and for further 3 weeks in a flask 
(120 ml CCM) under gentle agitation. Medium was replaced thrice a week.  
 
Pellet Culture of Human Chondrocytes (Chapter 7) 
Pellets of human chondrocytes were prepared  in V-bottomed 96-well plates (Nunc via Fisher 
Scientific GmbH, Schwerte, Germany) by pipetting 200 µl suspension of  2.5*105 
chondrocytes in culture medium into each well and subsequent centrifugation at 1300 rpm for 
5 min. After 24 hours for pellet consolidation growth factors were added to the complete 
chondrocyte culture medium (composition described above, Chondrocyte Isolation, Bovine 
Chondrocytes). 
 
Characterization of Polyurethane Scaffolds (Chapter 4) 
 
If not stated otherwise, the polyurethane scaffolds produced by polyMaterials AG 
(Kaufbeuren, Germany) is based on polycaprolactone-diol (molecular weight of 2000) and –
triol (molecular weight of 900) in equal parts. Furthermore, scaffolds derived from 
polymerisation of polycaprolactone-diol (MCI) (molecular weight of 1250) or 
polyvalerolactone (MVI) on mannitol and transformed with isophorondiisocyanate or 
polycaprolactone-diol polymerized on mannitol and transformed with 
hexamethylendiisocyanate (MCH) were characterized. Disc-shaped routine scaffolds as well 
as scaffolds in the shape of the external ear were investigated. Seeding efficiency tests were 
conducted to gain further insight in the characteristics of the scaffolds. Interconnectivity and 
pore structure were analyzed by scanning electron microscopy (SEM). 
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Seeding Efficiency Test                                           
For determination of seeding efficiency of routine scaffolds discs with a diameter of 5 mm 
and a height of 2 mm were applied. In case of the scaffolds in the shape of the external ear 
samples from different representative areas #1 - #6 (Fig. 1) were punched out to get an 
overview of the characteristics in the different areas of the ear-shaped scaffold. The thickness 
was determined and the required fibrin gel volume and the respective cell number, 
corresponding to the amount used for the routine scaffold discs were calculated. 
 
 
 
Figure 1: Areas # 1 - # 6 from which discs were punched out for seeding efficiency test. 
 
For the seeding efficiency test scaffolds were pre-treated and seeded with chondrocytes 
suspended in long-term stable fibrin gel as described above (Chondrocyte Culture on PU 
Discs). The calculated initial cell number seeded on the routine discs (5 mm diameter, 2 mm 
thickness) was 2.5*106 cells (in 40 µl fibrin gel). The seeded scaffold samples were incubated 
at 37° C for 45 min to allow gelation of the fibrin gel. Then the scaffold-fibrin gel 
combinations were covered with 4 ml of CCM and incubated over night in an incubator at 37° 
C, 95% humidity and 5% CO2. After 24 hours constructs were harvested. After removal of the 
medium constructs were washed with PBS and subjected to a digestion with papainase 
solution (papain suspension, Worthington via Cell Systems, St. Katharinen, Germany; 3.2 
U/ml in buffer) overnight and determination of the DNA content, i.e. the cell number. 
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Scanning Electron Microscopy (SEM) 
Scanning electron microscopy providing a deeper insight into the structure of the scaffold was 
applied for further characterization. For this purpose scaffold discs with a diameter of 5 mm 
were punched out of the ear-shaped scaffold (#1-6, see Fig. 1). Similarly discs from round 
scaffolds were prepared with a thickness of 2 mm and a diameter of 5 mm.  Then discs were 
mounted on aluminium stubs applying a conductive carbon tape (Leitabs, Plannet GmbH, 
Germany) and coated with gold by sputtering four times for 20 seconds (SEM autocoating 
Unit E5200, Polaron Equipment LTD, UK). Investigation of pore structure and 
interconnectivity was conducted using a JSM 840 scanning electron microscope (Jeol, Japan). 
 
Towards Osteochondral Constructs (Chapter 6) 
 
Selective Seeding Procedure 
For osteochondral constructs bilayered scaffolds with a diameter of 9 mm comprising a PU 
part (4 mm thickness) supposed for cartilage engineering and a hydroxyapatite-based 
composite part (2 mm thickness, 9 mm diameter) for bone culture were provided by 
polyMaterials (Kaufbeuren, Germany) in cooperation with the Friedrich-Baur-Institute 
(Bayreuth, Germany). Two types of bilayered scaffolds were distinguished. For one type of 
bilayered scaffolds, the composite part was plotted on a membrane, which covered the surface 
of the PU scaffold and which was introduced during the scaffold production process (“with 
membrane”). The second type was fabricated by plotting the composite-part directly on the 
open pores of the PU-part (“open”).  
First fibrin gel [23] with bromophenolblue (Serva, Heidelberg, Germany) was injected 
radially and selectively into the PU part of the bilayered scaffold combination (Figure 2) with 
a syringe to establish the insertion technique. The established procedure was then applied to 
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seed the PU part of the bilayered scaffold combination with 16.5*106 chondrocytes suspended 
in fibrin gel. Constructs were held in cell culture for 3 weeks. 
 
 
 
Figure 2: Selective gel insertion in PU part of scaffold combination 
 
According to the results (c.f. Chapter 6), in subsequent experiment, the PU part was reduced 
to 2 mm thickness. Consequently, the cell number was also distinctly reduced, as compared to 
the preceding experiment. Moreover, to optimize selectivity of the seeding procedure and to 
avoid insertion of fibrin gel with chondrocytes in the composite part, only 80% of the fibrin 
gel containing the cells (i.e. 3.7*106 chondrocytes per construct) was selectively injected into 
the PU part of the scaffold combination.  
In the following experiments the composite part was blocked during the seeding procedure 
with a thermo-reversible gelatine gel to increase selectivity in seeding, i.e. to ensure that 
exclusively the PU part was seeded with chondrocytes. The thermo-reversible gelatine gel 
described by Joly-Duhamel [30] was modified for this purpose. In brief, 1.12 g gelatine (from 
bovine skin, Sigma-Aldrich, Taufkirchen, Germany) were dissolved in 25 ml of a saccharose 
solution (64 g saccharose dissolved in 36 g Millipore water, 30 g of this syrup was diluted 
with 70 g Millipore water) at 50° C. Then the tempered (50° C) gelatine solution was 
subjected to sterile-filtration. 100 µl of the gelatine solution were inserted in the composite 
part of the combination scaffolds. The bilayered scaffolds were pre-treated with ethanol 70% 
for 5 min, then rinsed 5 times with PBS and sterilized by autoclave sterilization beforehand. 
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The constructs were kept at 4°C over night in 6-well plates. The PU part was seeded with 
3.7*106 cells suspended in 102 µl fibrin gel. During gelation of the fibrin gel in the incubator 
at 37° C for 45 min, the gelatine simultaneously became fluid again and could be removed by 
washing with PBS. Then the constructs were covered with 7 ml CCM. After 24 h the cell 
number was determined in the PU as well as in the composite part to analyze seeding 
selectivity. Cartilage development and cell distribution were also evaluated after 1 week in 
culture.  
 
Cartilage-Bone Co-Culture 
For the first actual co-culture combination scaffolds with a PU part of 4 mm thickness and a 
diameter of 9 mm were applied. They were seeded with chondrocytes in fibrin gel (16.5*106 
cells per construct) and after 1 week pre-cultivation in CCM the composite part of the 
scaffolds was seeded with GFP-labelled bone-marrow derived stem cells (BMSC). Constructs 
seeded with chondrocytes only served as control. After 3 days, constructs were harvested for 
determination of cell viability and cell distribution (Cooperation with research group Prof. 
Matthias Schieker, LMU Munich, Germany, BMSC seeding and viability testing was 
performed at the LMU). 
The second attempt towards cartilage-bone co-culture was conducted applying the modified 
system. Combination scaffolds with a PU part with the reduced thickness of 2 mm were 
seeded with fibrin gel with a distinctly reduced cell concentration, i.e. 3.7*106 cells per 
construct while the composite part was blocked with the thermo-reversible gelatine gel as 
described above. After 1 week of pre-culture, constructs were seeded with GFP-labelled 
BMSC. After 3 days constructs were harvested for determination of cell viability and cell 
distribution.  
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Effect of Growth and Differentiation Factor-5 (GDF-5) and Insulin on Expanded 
Chondrocytes (Chapter 7) 
 
Bovine Chondrocytes in Fibrin Gel  
For the preparation of fibrin gels seeded with expanded (P2) bovine chondrocytes, the cells 
were isolated, expanded and harvested as described above with some modifications. In order 
to investigate the influence of the application of growth factors during the expansion process 
on the capability of redifferentiation in subsequent 3D culture in fibrin gel [23] three 
experimental groups were created. The control group (Exp: CTR) was expanded without 
protein supplementation of CCM, the other two groups were expanded either in CCM 
supplemented with HuGDF-5 (kindly supplied by Biopharm, Heidelberg, Germany) at a 
concentration of 0.1 µg/ml (Exp: G 0.1) or in CCM supplemented with HuGDF-5 at a 
concentration of 0.1 µg/ml in combination with 2.5 µg/ml insulin (Sanofi-Aventis, Frankfurt/ 
Main, Germany) (Exp: G 0.1+I). After reaching second confluency (passage 2) cells were 
harvested for fibrin gel culture. 
5*106 passage 2 (P2) chondrocytes were suspended in 20 µl fibrinogen solution (100 mg/ml). 
20 µl of this suspension (containing 2.5*106 chondrocytes, due to the volume of the cells) 
were pipetted into a silanized glass ring place at the bottom of a 6-well culture plate. Then 
20µl of thrombin (5 U/ml) solution were added and gently mixed with the fibrinogen 
component. After 45 min for gelation at 37° C the glass ring was removed and the fibrin gels 
were covered with 4 ml of CCM. Each of the three groups was sub-divided into three groups 
(Fig. 3). The fibrin gels were cultured either in complete chondrocyte medium (CTR) or 
complete chondrocyte medium supplemented with 0.1 µg/ml HuGDF-5 (G 0.1) or the 
combination of HuGDF-5 0.1 µg/ml and insulin 2.5 µg/ml (G 0.1+I) for 21 days. Medium 
was changed thrice a week. After 21 days in culture constructs were weighed, cut into two 
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halves, one for histological examination one for biochemical analysis. The samples for 
biochemical analysis were freeze-dried prior to digestion. 
 
primary chondrocytes
P1
P2
Exp: CTR Exp: G 0.1 Exp: G 0.1+I
expansion
CTR
G 0.1
G 0.1 +I
CTR
G 0.1
G 0.1 +I
CTR
G 0.1
G 0.1 +I
 
 
Figure 3: Experimental design of the investigation of the effect of GDF-5 application in combination with 
insulin during expansion on the subsequent redifferentiation in fibrin gel 
 
Human Chondrocytes in Pellet Culture  
Pellets of human chondrocytes were prepared  in V-bottomed 96-well plates (Nunc via Fisher 
Scientific GmbH, Schwerte, Germany) by pipetting 200 µl suspension of  2.5*105 
chondrocytes in culture medium into each well and subsequent centrifugation at 1300 rpm for 
5 min. After 24 hours for pellet consolidation growth factors were added to the culture 
medium (CCM) (composition described above) containing 10% FBS and from then on the 
pellets received growth factor supplemented culture medium with each change of medium. 
Due to the results with bovine chondrocytes insulin was applied at 2.5 µg/ml (I 2.5), HuGDF-
5 at 0.1 µg/ml (G 0.1) and HuGDF-5 at 0.1µg/ml combined with insulin at 2.5 µg/ml (G 0.1 
+I). Control constructs received medium without growth factor supplementation, but with 
addition of the equal volume of the dilution buffer used as solvent for HuGDF-5 and insulin. 
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Effect of GDF-5 and Insulin on Chondrogenic Differentiation of Adipose - Derived Stem 
Cells (ASC) (Chapter 7) 
 
Human adipose - derived stem cells (ASC) (Promo Cell, Heidelberg, Germany) were 
expanded up to passage 3 in MSC growth medium (Promo Cell, Heidelberg, Germany). Then 
they were further expanded up to passage 6 in CCM.  
After reaching confluency for the 6th time (P6), cells were harvested for pellet culture. After 
detachment with trypsin cells were counted and 250 µl of the cell suspension containing 
2.5*105 cells were pipetted into wells of V-bottomed 96-well plates. Pellets were formed by 
centrifugation at 1300 rpm for 10 min. After 8 hours incubation for pellet consolidation 75 µl 
of the medium were removed, followed by addition of 175 µl growth factor containing CCM 
with the following final concentrations in the well: 0 (CTR), 2.5 µg/ml insulin (I 2.5), 
0.1µg/ml HuGDF-5 (G 0.1), 2.5 µg/ml insulin and 0.1 µg/ml HuGDF-5 (G 0.1 +I). Pellets 
were cultured for 21 days in an incubator at 37° C, 95% humidity and 5% CO2. Medium was 
changed thrice a week. Constructs were harvested for biochemical and histological 
assessment.  
 
Biochemical Analysis of Engineered Tissue 
 
Biochemical analysis of engineered constructs was conducted as previously described [24]. 
With the exception of pellets, constructs were cut into half after determination of wet weight 
(WW). In the case of pellet culture three pellets of each group were pooled for biochemical 
analysis. One half of the constructs or three pooled pellets respectively were digested with 
papainase solution (3.2 U/ml in buffer) over night (16 hours) at 60°C for subsequent 
determination of cell number, sulphated glycosaminoglycan (GAG) content and collagen 
content. The cell number was calculated from the DNA content which was determined by a 
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fluorometrical assay using Hoechst 33258 dye (Polysciences, Warrington, PA, USA) [31]. 
The content of GAG was assessed spectrophotometrically after reaction with 
dimethylmethylenblue (Sigma Aldrich, Taufkirchen, Germany) at 525 nm as chondroitin 
sulphate (ICN, Aurora, Ohio, USA) [32, 33]. The hydroxyproline content was determined 
after acid hydrolysis and reaction with chloramine-T (Merck, Darmstadt, Germany) and p-
dimethylaminobenzaldehyde spectrophotometrically at 557nm [34]. In order to obtain the 
total amount of collagen a hydroxyproline to collagen ratio of 1:10 was applied [35]. 
 
Histochemical and Immunohistochemical Analysis of Engineered Tissue 
 
Histological samples were fixed with 2% glutaraldehyde (15-30 min, dependent on construct 
characteristics) and stored in 10% formalin (both from Merck, Darmstadt, Germany). 
Formalin-fixed samples were then embedded into paraffin and cross-sectioned into 5µm 
slices. The cross-sections were then stained with safranin-O, fast green and haematoxylin 
[36]. 
For immunohistochemistry the cross-sections were deparaffinized before staining. The slides 
were incubated overnight with primary antibody solution dissolved at a ratio of 1:500 for type 
I collagen antibody (col-1) (Sigma-Aldrich, Taufkirchen, Germany) and 1:25 for type II 
collagen antibody (CIIC1) (DSHB, University of Iowa, USA) followed by incubation with 
secondary biotinylated antibody and subsequently with streptavidin-HRP (both Dako, 
Hamburg, Germany). Staining was performed with 3,3’-Diaminobenzidine Enhanced Liquid 
Substrate System (Sigma-Aldrich, Taufkirchen, Germany). Nuclei were counterstained with 
Weigert’s haematoxylin. 
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Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction 
 
Pellets of expanded human chondrocytes were subjected to RT-PCR. RNA extraction was 
conducted using RNeasy Mini Kit (Qiagen, Hilden, Germany) in accordance to the 
manufacturer’s protocol. Superscript II (Invitrogen, Karlsruhe, Germany) was applied for 
synthesis of cDNA in the presence of oligo-dt primers, nucleotides and ribonuclease inhibitor 
(Invitrogen, Karlsruhe, Germany). 
Quantitative real-time RT PCR was performed with Platinum Sybr Green qPCR Supermix 
(Invitrogen, Karlsruhe, Germany) with ABI Prism 7000 (Applied Biosciences, Darmstadt, 
Germany). Glyceraldehyde phosphate dehydrogenase (GAPDH) served as housekeeping 
gene. Expression levels of the target genes were normalized to GAPDH. Expression levels 
were also normalized to levels of the control samples (set as 100%). Sequences of the applied 
primers are given in Table 1. 
 
Primer Sequence 
GAPDH fw: 5’- gaa ggt gaa ggt cgg agt c –3’ 
rv: 5’- gaa gat ggt gat ggg att tc – 3’ 
Col1a1 fw: 5’- agg gcc aag acg aag aca tc -3’ 
rv: 5’ - aga tca cgt cat cgc aca aca – 3’ 
Col2a1 fw: 5’- ttc agc tat gga gat gac aat c -3’ 
rv: 5’ - aga gtc cta gag tga ctg ag – 3’ 
 
Table 1:  Sequences of the primers applied for RT-PCR 
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Statistical Evaluation 
 
The obtained data were analyzed using ANOVA (one way analysis of Variance) with 
subsequent Tukey test to determine statistical significances using SigmaStat 3.5 for Windows. 
In case of failure of the normality test analysis of variance on ranks was conducted (Kruskal 
Wallis analysis of variance on ranks indicated by 1with subsequent Tukey test).  
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Introduction 
 
 
The external ear is one of the most complex 3-dimensional (3D) structures of the external 
body [37] and consists of three major components, the helix-antihelical complex, the conchal 
and the lobule. The 3D shape of the external ear is maintained by auricular cartilage, which is 
constituted by elastic cartilage [38]. Loss of auricular cartilage due to trauma, tumour 
resection or congenital defect is a major challenge in craniofacial surgery [1, 2]. The 
incidence of microtia is 100 to 150 cases per year in Germany [39]. There is no universally 
accepted classification of the severity of microtia. A commonly applied system was 
introduced by Tanzer and modified by Aguilar and distinguishes three grades of severity. 
Grade I is characterized by a slightly smaller than normal ear with basically normal features. 
A rudimentary and malformed auricle, which however displays some noticeable components, 
is classified as grade II. Grade III describes a severely reduced ear with a small clot of 
malformed tissue and anotia [37]. The most prevalently applied therapeutical method is costal 
cartilage graft reconstruction, which was established and described by Nagata and Brent [40]. 
Temporoparietal fascia flap, alloplastic implants and the combination thereof as well as 
prosthetic aids are further options for the treatment of microtia. All of the mentioned methods, 
however, are associated with certain disadvantages. Reconstruction by costal grafts on the one 
hand is reproducible if conducted by an experienced, skilled surgeon, but on the other hand 
requires multiple surgical procedures and causes donor site morbidity, as visible chest wall 
deformities [37]. Using the temporoparietal fascia is a procedure requiring special precaution. 
Alloplastic implants made of silicone or polypropylene are easily available, inherently stable, 
but also bear the risk of infection, extrusion, biocompatibility and uncertain long-term 
stability [41]. Prosthetic aids have not been tolerated and accepted very well in the past due to 
problems like skin irritation, change of the colour of the prosthesis over time. Consequently, 
established surgical methods for the reconstruction of the external ear applying autogenous 
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tissue represent the state of the art. Cosmetic results, however, are often unsatisfactory. Thus, 
tissue engineering is considered to be a promising alternative. For less complex shapes, 
engineering neocartilage applying scaffolds and chondrocytes has already been established 
using various scaffold materials. Here, the goal is to create an individual, aesthetic and 
autologous ear-shaped cartilage construct for the individual patient. This implicates the 
creation of a custom-made scaffold using the patient’s healthy ear as a model, which is seeded 
with autologous chondrocytes, pre-cultured in vitro and then transplanted.  
Rapid prototyping offers the opportunity to generate even complex, individual scaffolds for 
tissue engineering purposes [42–44]. Data needed for the fabrication of a custom-made mold 
in the shape of the human external ear can be acquired by imaging techniques like computer 
tomography (CT). Further data processing and conversion permits the production of the 
silicone mold through computer aided design (CAD) and computer aided manufacturing 
(CAM). In the presented study, a silicone mold was manufactured in a two-step process 
starting with the generation of a positive using stereolithography and subsequent generation of 
the silicone mold as negative. Subsequently, the silicone mould was used for the production 
of the scaffolds.  
Porous scaffolds are a key-component in cartilage tissue engineering. Scaffolds have to 
comply with various requirements. They serve as a space-filling material and provide the 
three-dimensional shape for the desired engineered tissue as well as retention of the newly 
synthesized extracellular matrix. For tissue engineering approaches, soft hydrogels as well as 
sponge-like porous scaffolds are applied. Hydrogels are directly injectable into the defect and 
are easy to prepare, but often lack the mechanical stability and are not forming. The forming 
characteristic is one of the great advantages of porous scaffold materials, besides their 
mechanical stability. 
Polymers widely used for the preparation of porous scaffolds are, for example 
polhydroxyacids, polylactides or polyglycolides. Th
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well as proliferation, but are on the other hand characterized by limited elasticity and 
deformability. The latter characteristics, however, are considered to be of great importance for 
scaffolds applied for cartilage tissue engineering. Elastomeric polyurethanes have gained 
increasing interest as an alternative material due to their molecular stability in vivo and in 
case of the biodegradable polyurethanes due to the non-toxic degradation products [45]. 
Moreover, they have been used in many implantable devices in clinical application [24]. 
Previously, the benefit of combining a hydrogel and a porous scaffold thus exploiting the 
inherent advantages of each scaffold type was demonstrated in the group [24]. Fibrin gel was 
chosen as hydrogel and polycaprolactone based polyurethane scaffolds [28] as mechanically 
stable component. Being physiological fibrin gel does not raise questions concerning 
biocompatibility. In combination with the porous scaffold, it provides a good retention of the 
cells as well as of the produced new extracellular matrix. It has also been reported that 
chondrocytes retain their round morphology and do not dedifferentiate when embedded in 
fibrin gel. It also allows cell migration within the scaffold [46].  
In this study, the PU-fibrin system was utilized for the generation of engineered complex 
cartilage constructs. Before generation of an ear-shaped cartilage construct, the impact on 
cartilage development of suspending the cells in the thrombin or in the fibrinogen component 
when preparing the fibrin gel was investigated. A second experiment was conducted to 
enlighten the role of the fibrin gel on cell distribution and cartilage development in the 
polyurethane scaffold by directly seeding PU scaffolds without fibrin gel. Ear-shaped 
scaffolds (polyMaterials AG, Kaufbeuren, Germany) were manufactured in silicone molds 
produced by rapid prototyping techniques (KL Technik, Krailing, Germany). 
Then the established concept of combining fibrin gel and PU scaffolds for cartilage tissue 
engineering was transferred to the complex ear-shaped PU scaffolds using bovine 
chondrocytes and a first prototype of ear-shaped cartilage was analyzed. 
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Results 
 
Comparison of Two Seeding Procedures 
The fibrinogen solution used in forming the fibrin gels is comparatively highly viscous. By 
suspending the chondrocytes in the fibrinogen solution, the viscosity is even increased 
making its handling difficult. Thus, the seeding procedure may be improved by suspending 
the chondrocytes in the thrombin solution, the other component in fibrin gel formation. In 
order to guarantee reproducibility of the results a comparison between the two methods was 
conducted. Comparing wet weight and cell number of both groups after 21 days showed only 
a slightly higher wet weight and cell number for the group seeded with chondrocytes 
suspended in the thrombin solution before mixture with the fibrinogen component and 
insertion into the scaffold discs (Fig. 4A-C). Considering the content of extracellular matrix 
(ECM) (Fig. 4D,E,H,I) and the activity in synthesizing extracellular matrix components, i.e. 
glycosaminoglycans (Fig. 4F) and collagen (Fig. 4G) there was no detectable difference 
between the two methods.   
Glycosaminoglycan (GAG) distribution was determined by staining cross-sections of both 
groups with safranin-O.  After 21 days in culture both groups exhibited substantial amounts of 
GAG homogenously distributed in the construct, indicated by an intense and evenly 
distributed red staining without a subtle distinction between the two experimental groups (Fig. 
5). 
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Figure 4 (p. 40): Wet weight (A), cell number (B-C), GAG-content (D,F,H), and collagen content (E,G,I) of 
cartilage constructs after 21 days of culture. Cells in F: chondrocytes were suspended in the fibrinogen 
component before mixture with thrombin solution and subsequent insertion into the polyurethane scaffold disc; 
Cells in T: chondrocytes were suspended in thrombin solution before mixture with fibrinogen component and 
following insertion into the polyurethane scaffold disc. Data represents the average ± SD of four independent 
constructs. 
 
 
 
Figure 5: Glycosaminoglycan (GAG) distribution in cross-sections of cell-fibrin-PU scaffold constructs after 21 
days in culture. GAG was stained red with safranin-O. Cells in F: chondrocytes were suspended in fibrinogen 
component before mixture with thrombin solution and subsequent insertion into the polyurethane scaffold disc; 
cells in T: chondrocytes were suspended in thrombin solution before mixture with fibrinogen component and 
following insertion into the polyurethane scaffold disc.   
 
Consequently, for further experiments the procedure was adjusted and the chondrocytes were 
suspended in the thrombin solution before mixture with the fibrinogen solution and 
subsequent insertion into the scaffold, as the thrombin solution displayed a comparatively 
lower viscosity. Thus, the suspension of chondrocytes in the thrombin solution was much 
easier to process in the seeding procedure. 
Chapter 3 – Chondrocyte Cell Culture Applying PU Scaffolds for Auricular Reconstruction 
 
 -  - 42 
Influence of the Fibrin Gel on Cell Distribution and Development of Cartilage Tissue within 
PU Scaffolds 
In a second experiment, the role of the fibrin gel particularly on cell distribution within the 
PU scaffold discs was investigated by seeding the constructs without fibrin gel and 
subsequent comparison with the results obtained applying the combination of fibrin gel and 
PU scaffolds (see Figs. 4 & 5). The wet weight was increased over the 21 days in culture (Fig. 
6A). For seeding without fibrin gel, the extraordinarily high standard deviation on day 3, 
regarding the mean of the wet weight as well as of the cell number, indicated a low 
reproducibility of the seeding procedure without the fixation of the cells in the scaffold with 
the fibrin gel (Fig. 6A-C). Cell number on day 3 lay far behind the expected cell number, as 
initially 2.5*106 chondrocytes were applied for each scaffold. From day 7 onwards cell 
number increased (Fig. 6B). Matrix content, i.e. glycosaminoglycans (GAG) per wet weight 
(Fig. 6D) and collagen per wet weight (Fig. 6E), also increased during the culture period. 
GAG production (GAG/ cell [ng]) reached already a plateau on day 7, collagen production 
(collagen/ cell [ng]) on day 14, hence further increase in matrix was due to proliferation of the 
cells (Fig. 6F,G). Total GAG and collagen, however, ascended over the entire culture period 
(Fig. 6H,I). 
For the purpose of visualization of cell distribution within the pores cross-sections were 
stained with haematoxylin/ eosin (H&E).  In order to analyze the development and location of 
GAG in the constructs, cross-sections were subjected to safranin-O staining. H&E staining of 
the cross-sections showed a relatively high cell number at the walls of the pores from the 
beginning of the culture period onwards. This phenomenon was ascribable to the adherence of 
the cells to the walls during the seeding process. Over the culture period the pores were filled 
with cells and matrix, with a lower cell density located towards the centre of the scaffold. 
Remarkably, the structure resembled the zonal organization observed in native cartilage. 
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Figure 6 (p. 43): Wet weight (A), cell number (B,C), GAG content (D,F,H), and collagen content (E,G,I) of 
cell-PU scaffolds on d3, d7, d14 and d21 of culture. Data represents the average ± SD of three independent 
constructs  
 
 
 
Figure 7:  Upper rows: Haematoxylin/Eosin staining of the nuclei counterstained with eosin (blue coloured) of 
the cross-sections of the polyurethane scaffold discs directly seeded with chondrocytes on day 3 (d3), day 7 (d7), 
day 14 (d14) and day 21 (d21). Lower rows: Glycosaminoglycan (GAG) distribution in cross-sections of 
polyurethane scaffold discs seeded with chondrocytes. GAG was stained with safranin-O. 
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Safranin-O stained cross-sections displayed a very homogenous and intense red staining of 
GAG already on day 3, indicating an early start of cartilaginous matrix production, and 
development of a homogenous cartilaginous construct over the culture period of 21 days (Fig. 
7). Comparing the stained cross-sections of discs seeded with chondrocytes suspended in 
CCM (Fig. 7), and those seeded with chondrocytes suspended in fibrin gel (Fig. 5), cell 
distribution was significantly more homogenous when using fibrin gel. 
 
Ear-Shaped Cartilage Constructs Combining Fibrin Gel and PU Scaffolds 
Due to the easier processing using the thrombin solution to suspend the cells with given 
comparability of the results to those of the original method (see above), the modified method 
was applied for seeding the ear-shaped PU scaffold. 
Figure 8 shows the ear-shaped construct obtained after 28 days in culture. Macroscopic 
inspection of the yielded cartilage construct suggested that it contained a relatively high 
amount of culture medium, indicated by the red colour.  
 
 
 
 
Figure 8: Development of an ear-shaped cartilage construct. After seeding it was cultured in a custom-made 
bioreactor and harvested after 28 days in culture. 
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Figure 9: Section planes and localization of the samples taken for biochemical and histological analysis to 
obtain a comprehensive analysis of the development of cartilage tissue covering the whole construct after 28 
days in culture. 
 
In order to facilitate a comprehensive analysis of the whole construct with high spatial 
resolution, samples (# 1 – 7) were punched out from various section planes of the ear-shaped 
construct (Fig. 9) for biochemical and histological analysis. 
Due to the fact that the discs obtained from the ear-shaped cartilage for biochemical analysis 
had a slightly smaller diameter (3 mm) than the routine discs, which served as a control 
(CTR), and furthermore differed in thickness depending on their location in the ear-shaped 
construct, wet weight could not really be compared (Fig. 10A). The cell number per wet 
weight was much smaller in the samples derived from the ear than in the control group 
(CTR).  The same applied to the content of glycosaminoglycans and collagen per wet weight 
(Fig. 10C, E). This was plausible considering the comparatively low cell number in the ear-
shaped construct. Regarding GAG production per cell, however, the performance of the 
chondrocytes in the ear-shaped construct reached a level comparable to the chondrocytes in 
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the control discs (Fig. 10D). The collagen production, however, expressed as collagen [ng] 
per cell was also remarkably lower in the samples of the ear-shaped construct in comparison 
with the control group (CTR) (Fig. 10F). 
In accordance with the results of the biochemical analysis, glycosaminoglycan distribution in 
the cross-sections was neither coherent nor homogenous. Single cells or conglomerates of 
some chondrocytes embedded in cartilaginous matrix could be detected in every section 
plane, but without forming a coherent cartilaginous construct, whereas in the control discs an 
intense and homogenous safranin-O staining throughout the pores of the routine disc was 
detected indicating production of a coherent cartilage tissue (Fig. 11). 
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Figure 10: Wet weight (A), cell number (B), GAG content (C-D), and collagen content (E-F) of samples taken 
from representative section planes (1-7) of the ear-shaped construct after 28 days in culture. Round polyurethane 
scaffold discs seeded with chondrocytes in fibrin gel served as control (CTR).  CTR: Data represents the average 
± SD of three independent samples. Samples from the ear: Data represents the average of two or three samples 
from the respective section plane with the exception of section plane # 3, where only 1 sample could be 
obtained; error bars represent the minimum and maximum values. 
 
 
 
 
Chapter 3 – Chondrocyte Cell Culture Applying PU Scaffolds for Auricular Reconstruction 
 
 -  - 49 
 
 
Figure 11: Glycosaminoglycan (GAG) distribution in cross-sections of discs punched out of the representative 
sections indicated in figure 9 and of control discs (CTR) of round-shaped routine polyurethane scaffolds. GAG 
was stained red with safranin-O. 
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Discussion 
 
The first experiment evidenced that it was irrelevant for the development of cartilage tissue, if 
the chondrocytes were suspended in the fibrinogen or in the thrombin solution before mixture 
with the respective second component and subsequent injection of the mixture into the PU 
scaffold. The great benefit of the adjustment of the procedure, i.e., using the thrombin 
solution for suspending the cells, was an easier processing leading to a more robust procedure. 
A comparison with the previous procedure demonstrated no difference in outcome (Figs. 4 & 
5) and guaranteed comparability with the experiments previously conducted in the group.  
In the second experiment, in which PU scaffolds were seeded without fibrin gel, the role of 
the fibrin gel with respect to cell distribution and structure of the engineered cartilage tissue 
was enlightened. In comparison with the tissue development and yielded cell numbers in the 
first experiment, the great advantage of combining fibrin gel and PU scaffold for cartilage 
tissue engineering became evident in terms of higher retention of chondrocytes and newly 
synthesized extracellular matrix (Figs. 4 & 5 in comparison with Figs. 6 & 7). Another aspect 
is the homogeneity of cell and matrix distribution which was given to a high extent when 
combining fibrin gel and PU scaffold, whereas when seeding the scaffold with a suspension 
of chondrocytes in culture medium, cells were found to adhere basically to the wall of the 
pores of the scaffold. Over time the highest concentration of cells remained at the walls of the 
pores, whereas approaching the centre the density decreased (Fig. 7). Interestingly, this 
rendered a structure highly resembling the zonal structure displayed in native cartilage [4]. 
Even though the zonal organization was not intended in this approach towards auricular 
cartilage engineering, the possibility to mimic zonal organization implies options for further 
research towards designing cartilage constructs, which may also be used for studies 
investigating cartilage physiology. Another approach described in literature tried to obtain a 
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zonal organization by application of bilayered photopolymerized hydrogels, which was used 
to investigate the effect of the zonal organization on the properties of the yielded tissue [47].  
After optimization in terms of handling of the combination of polyurethane scaffold and fibrin 
gel the system was transferred to the complex 3D structure of the human external ear. In 
previous studies, other groups also approached reconstruction of the external ear by tissue 
engineering methods. One group also suspended the chondrocytes in fibrin gel, but instead of 
the porous scaffold the gel was put between two layers of lyophilized perichondrium [48]. 
Another group used bioresorbable PGLA-PLLA polymer scaffolds which were seeded with 
human nasal septal chondrocytes suspended in fibrin gel. This approach rendered solid tissue 
and substantial neo-cartilage formation with the presence of cartilage specific matrix 
components after 6 weeks of pre-culture in vitro and subsequent in vivo implantation for 6-12 
weeks [49]. Another  possibility was represented by using an ear model, produced by using 
clay modelling, to produce ear-shaped scaffolds of PGA (poly (glycolic acid)), PCL (poly (ε-
caprolactone)) and P-4HB (poly (4-hydroxybutyrate)) for culture of chondrocytes isolated 
from adult sheep ears [41].  Liu et al also employed CAD/CAM to engineer a human ear-
shaped cartilage construct. PGA scaffolds coated with PLA to enhance stability of the 
scaffold were seeded with chondrocytes isolated from newborn articular swine cartilage [50].  
None of these studies provided a comprehensive analysis of the whole construct with high 
spatial resolution in contrast to the investigation presented here. Analyzing samples from 
different representative parts of the ear-shaped cartilaginous construct allows to judge, if 
cartilage tissue is really coherent and homogenous. Furthermore with the exemption of the 
scaffolds applied by Liu et al., the ear-shaped scaffolds applied were very simple and crude in 
shape. They only resemble the human external ear, but are not shaped with the individual 
details of the patient. Liu et al. also applied CAD/ CAM to produce the ear-shaped scaffold. 
Within this study, although in the generated ear-shaped cartilage construct cartilaginous ECM 
could be detected to some extent throughout the construct (Fig. 11), particularly section plane 
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1, 3 and 5 a coherent cartilage construct was not achieved in this prototype. Further 
experiments have to be conducted to elucidate the reasons for the not yet satisfying 
development of cartilaginous tissue. Pore size and interconnectivity of the scaffold are 
particularly crucial parameters in cartilage engineering. First of all seeding efficiency may be 
compromised by an unfavourable pore structure. If the seeding efficiency is too low, a 
comparably low number of chondrocytes affecting subsequent tissue development. But ECM 
formation and generation of a coherent cartilaginous tissue can also be directly negatively 
affected by a too low pore size and interconnectivity. Grad et al., for instance, showed that 
decreasing pore size did not improve phenotype expression and cartilaginous matrix synthesis 
of incorporated chondrocytes, but rather restricted nutrient supply [51]. A careful analysis of 
the scaffold used in this study with special attention paid to its pres structure appears 
inevitable. This may then facilitate rational changes in the polymer composition of the 
scaffold and the optimization of the scaffold production process.  
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Introduction 
 
In Chapter 3, engineering of an ear-shaped cartilage construct applying the combination of 
fibrin gel and ear-shaped PU scaffolds was described and the results of the first prototype are 
given and discussed. As this prototype turned out to be very promising, but did not display the 
development of a really coherent cartilage construct, here possible reasons were investigated 
in order to allow for optimization.  First the seeding efficiency had to be determined and 
compared to round routine discs. A low seeding efficiency would lead to a low amount of 
total matrix synthesized in the whole construct due to a low number of chondrocytes 
synthesizing extracellular matrix (ECM) components. Moreover, the scaffolds had to be 
further characterized as pore size and interconnectivity have a great impact on seeding 
efficiency, nutritive supply and retention of the newly synthesized matrix. Highly porous 
polymeric scaffolds are sometimes associated with the problem of low retention of the newly 
synthesized extracellular matrix, especially when mechanic stress is applied. On the other 
hand, a large pore size and an interconnective pore structure are required to ensure adequate 
access to nutrients. Pore size and interconnectivity are, thus, crucial characteristics of the 
scaffold. In order to enlighten the impact of pore size on the yielded quality of the 
cartilaginous construct Grad et al. studied cartilage development in polyurethane scaffolds of 
three different pore sizes. This study clearly evidenced that decreasing pore size restricted 
nutrient supply without having any positive effect [51]. Here, scanning electron microscopy 
(SEM) and seeding efficiency testing were done to characterize the ear-shaped PU scaffolds 
with spatial resolution.  
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Results 
 
Several ear-shaped scaffolds with slight variations in polymer composition (all manufactured 
by polyMaterials AG, Kaufbeuren, Germany) were investigated with regard to seeding 
efficiency and pore structure. As the results were very similar, here one example is shown in 
detail. Ear 7 (internal number) was an ear-shaped polyurethane scaffold of the mannitol-based 
MVI-type. For cell seeding experiments, disc-shaped samples were punched out from various 
section planes of the ear-shaped construct. The cell seeding efficiency was determined to be 
very poor, with on average less than 30% of the theoretically possible 2.5*106 cells within the 
construct.  
 
 
 
Figure 12: SEM analysis of ear-shaped polyurethane scaffold (MVI type, ear 7).           
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The unsatisfying results in the seeding efficiency test could be well correlated to SEM images 
revealing clear deficits in terms of interconnectivity for the tested material (Fig. 12). 
Nevertheless, the SEM images displayed that the pore structure was homogenous throughout 
the whole ear-shaped polyurethane scaffold (Fig. 12). 
 
 
 
Figure 11: Further SEM images from representative parts of an ear-shaped PU scaffold. 
 
In order to facilitate a deeper insight in the structure of the pores, representative images were 
obtained in different magnifications (Fig. 13). The larger magnifications revealed that the 
pores are either connected by very small holes or completely unconnected. Only two out of 
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six samples (sample # 4 and # 5) showed interconnective pores, whereas the exposure of 
sample # 6 was characterized by domination of solid polymer. These insights showed the 
potential but also demanded optimization in order to obtain an interconnective ear-shaped 
scaffold.  
Subsequently produced variants of PU scaffolds were tested using SEM in order to allow 
conclusions by polyMaterials AG concerning the applied formulations and the resulting pore 
size and interconnectivity. Simultaneously, physico-chemical treatments to increase 
interconnectivity were imposed on the scaffolds and evaluated (Table 2). As physico-
chemical treatment procedures did neither increase pore size nor interconnectivity, data is not 
shown here. 
 
# treatment procedure evaluation 
I with/without ethanol treatment (70%, 5 min), five times rinsing with PBS, autoclave 
sterilization, 45 min boiling water 
seeding 
efficiency test 
II 45 min sodium hydroxide (Merck, Darmstadt, Germany) solution (3%) at 60°C,  
thrice 15 min PBS, ethanol (70%, 5 min), five times rinsing with PBS, autoclave 
sterilization 
seeding 
efficiency  
III ethanol (70%, 5 min), five times rinsing with PBS, autoclave sterilization, 45 min 
boiling water 
seeding 
efficiency 
SEM 
IV argon or nitrogen plasma (Reinhausen Plasma GmbH, Regensburg, Germany), 
ethanol (70%, 5 min), washing with PBS, autoclave sterilization, 45 min boiling 
water 
seeding 
efficiency, 
SEM 
 
V ethanol (70%, 5 min), washing with PBS, freezing in water, 45 min sodium 
hydroxide solution (3%) at   60° C 
SEM  
VI freezing in ethanol, vacuum SEM  
VII ethanol (70%, 5 min), five times rinsing with PBS, autoclave sterilization, freezing 
(–80° C), vacuum (1.2*10-2 mbar) at -78° C (approx.6h),  
vacuum overnight after removal of cooling 
SEM   
VIII isopropanol (70%, 5-10 min), vacuum (70 mbar, 7min), ventilation, vacuum (70 
mbar, 7 min), removal of isopropanol (2 mbar, 10 min),  
70° C (10 min) or  microwave  (3 min) 
SEM  
 
Table 2: Applied physico-chemical treatment procedures to increase interconnectivity and pore size of the 
scaffolds. 
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Discussion 
 
In general, there are several requirements for scaffolds applied for cartilage tissue 
engineering. They provide a highly porous, interconnected network, allowing cell growth and 
fluid exchange for nutrient supply and removal of metabolic products. Furthermore, they have 
to be biocompatible and bioresorbable with controllable degradation. Suitable surface 
chemistry for cell attachment, proliferation and differentiation are also essential. Moreover, 
the scaffold material ought to display mechanical properties suitable for the site of 
implantation [14, 52].  
Pore size and interconnectivity represent especially crucial characteristics of the scaffold as 
they decisively influence nutrient availability, but also retention of newly synthesized 
extracellular matrix. SEM analysis of the ear-shaped polyurethane scaffolds revealed that in 
some areas of the scaffold interconnectivity as well as pore size was satisfying, whereas in 
other parts of the construct the structure was dominated by solid polymer, small pores and 
poor interconnectivity. Insufficient interconnectivity precludes a homogenous distribution of 
the chondrocytes suspended in fibrin gel and consequently the development of a coherent 
cartilage construct. Low exchange rates of nutrients and metabolic waste further contribute to 
the development of inferior cartilage tissue. The results obtained here provide a highly 
probable explanation for the comparatively weak engineered cartilage observed within the 
ear-shaped construct in Chapter 3. Nevertheless, the scaffold material resisted mechanical as 
well as thermal treatment, which indicates the stability of the material. This stability is 
required when implanting the constructs or if mechanical stimuli are already applied during in 
vitro culture. 
In conclusion, the polyurethane scaffolds represent a scaffold material, particularly in the 
shape of the external human ear, with a great potential for clinical application as being 
biocompatible and biodegradable. They are also characterized by mechanical stability which 
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is required for implantation and for form stability. However, so far, the pore structure within 
the ear-shaped constructs investigated here prevented the development of coherent cartilage 
tissue.   
New material variants of PU scaffolds are currently under investigation.  
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Introduction 
 
Loss of auricular cartilage due to trauma, tumour resection or congenital defects represents a 
challenge in craniofacial surgery [1, 2]. Due to aesthetic deficits and other disadvantages 
associated with the currently applied surgical methods for ear reconstruction using autologous 
costal grafts, tissue engineering is considered to be a promising alternative for the established 
approaches.  
Cartilage tissue engineering using scaffolds and chondrocytes has already been established for 
a large variety of scaffold materials [3, 9, 14] Custom-made scaffolds for the individual 
patient seeded with autologous chondrocytes are considered to render aesthetic implants. 
Rapid prototyping technologies allow the creation of even very complex, individual scaffolds 
as needed for external ear reconstruction [42-44].  
Oligo (poly (ethylene glycol) fumarate- (OPF-) based hydrogels are often used for tissue 
engineering applications, particularly for release of bioactive molecules like growth factors 
[53–55], but also as a cell carrier for differentiation and culture of cells [56, 57]. OPF 
hydrogels are mainly used as injectable biodegradable system [58]. The biocompatibility of 
pre-crosslinked gels from various OPF-formulations and leachable fractions has been shown 
in vitro and in vivo [58, 59]. 
In this study, different compositions of OPF scaffolds were investigated for application in the 
manufacture of complex 3-dimensional (3D) constructs such as the human external ear. For 
this purpose, certain mechanical properties are required, which can be influenced by the 
composition of the used polymer (Polymer and scaffold production were performed within 
research group by M. Henke.). At first, the influence of the OPF formulation on engineered 
cartilage tissue was assessed using simple disc-shaped scaffolds. Subsequently, the best suited 
composition for creating highly complex 3D scaffolds was chosen. The ear-shaped OPF 
scaffolds were fabricated in a silicone mold, which was created applying rapid prototyping 
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methods including computer assisted design and manufacture (CAD/ CAM) by KL-Technik 
(Krailing, Germany). After sterilization by γ-irradiation, the ear-shaped scaffolds were seeded 
with chondrocytes suspended in fibrin gel in order to evaluate the potential of the material for 
generation of complex 3D cartilage constructs. 
 
Results 
 
Investigation of Development of Cartilage Tissue in Different OPF Scaffolds 
In the first part of the study, the influence of the scaffold formulation on the yielded cartilage 
tissue was evaluated. Furthermore, the combination of OPF scaffolds with fibrin gel was 
compared to OPF scaffolds alone with respect to development of cartilaginous tissue. After 28 
days of culture, constructs were harvested and analyzed.  
 
 
 
Figure 14: Macroscopic appearance of OPF foams (1 – 3) seeded with chondrocytes (- fibrin gel) and with 
chondrocytes suspended in fibrin gel (+ fibrin gel) after 28 days in culture.  
 
The macroscopic appearance of the constructs after the culture period was characterized by a 
higher amount of medium inside the directly seeded OPF scaffolds compared to the scaffolds 
seeded with chondrocytes suspended in fibrin gel, which appeared more yellowish (Fig. 14). 
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A higher diffusion of medium into the construct might be due to lower density of extracellular 
matrix (ECM) in the construct. Comparing the three different scaffold types (foam 1 - 3), no 
difference could be observed macroscopically 
Comparing wet weight (Fig. 15A) and cell number (Fig. 15B,C) no difference was detectable 
between the three different scaffold types. The relatively low cell number after 28 days, which 
was equivalent to the calculated cell number initially seeded onto the scaffolds, was due to an 
inevitable loss of cells during the seeding procedure (Fig. 15B).  
Glycosaminoglycan (GAG) content and production (Fig. 15D,F,H) indicated substantial 
production of cartilage matrix in all three scaffold formulations. The same applied to collagen 
content and production (Fig. 15E,G,I). Statistical evaluation of the results of the biochemical 
analysis showed no difference between the three different scaffold formulations could be 
detected. 
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Figure 15 (p. 65): Wet weight (A), cell number (B, C), GAG content (D,F,H) and collagen content (E,G,I) of 
cartilaginous constructs generated with OPF scaffolds (1-3) seeded with primary bovine chondrocytes after 28 
days in culture. Data represents the average ± SD of three independent constructs.  
 
In a second study the development of cartilaginous tissue was evaluated when combining 
fibrin gel and OPF scaffolds.  
Wet weight of the constructs seeded with chondrocytes in fibrin gel was much higher than of 
the constructs directly seeded with chondrocytes suspended in CCM (approximately 100 mg 
higher in each group) (Fig. 16A). Cell number (Fig. 16B,C) was also approximately 100% 
higher than cell number in the corresponding samples of OPF scaffolds directly seeded with 
chondrocytes. The cell number reached two times the initial cell number seeded onto the 
scaffold by insertion of fibrin gel with suspended chondrocytes. 
Analysis of GAG production (Fig. 16) and GAG content (Fig. 16D,H) proved the 
development of substantial amounts of cartilage matrix. Collagen content (Fig. 16E,I) and 
collagen production (Fig. 16G) also indicated the development of cartilage tissue over the 
period of 4 weeks. Comparing the results of the different foam formulations no difference 
could be detected. Comparing the yielded results for GAG and collagen production (GAG/ 
cell and collagen/ cell) of the combination constructs with the constructs seeded without fibrin 
gel, there was also no difference detectable between the constructs seeded with and without 
fibrin gel. However, as approximately a two-fold increase in cell number was reached in the 
OPF-fibrin-combination, there was also approximately a two fold-increase observed in GAG 
and collagen (Figs.15 & 16).  
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Figure 16 (p. 67): Wet weight (A), cell number (B,C), GAG content (D,F,H) and collagen content (E,G,I) of 
cartilaginous constructs generated with OPF scaffolds (1-3) seeded with primary bovine chondrocytes in fibrin 
gel after 28 days in culture. Data represents the average ± SD of three independent constructs.  
 
Staining for GAG on cross-sections of the constructs proved a predominantly homogenous 
and substantial production of cartilaginous matrix throughout the constructs seeded with 
chondrocytes suspended in CCM (Fig. 17). OPF hydrogels seeded with chondrocytes 
suspended in fibrin gel displayed large areas intensely stained red, although areas with faint 
safranin-O staining were also detected (Fig. 17). Similar to the results of the biochemical 
analysis no difference between foam 1 to 3 was detectable, neither when directly seeded nor 
in case of seeding with chondrocytes suspended in fibrin gel. Fibrous tissue, however, could 
only be detected at the edges of single constructs as a margin with a faint green staining (Fig. 
17 foam 1 + fibrin gel, foam 3 + fibrin gel). 
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Figure 17: Glycosaminoglycan (GAG) distribution in cross-sections of OPF scaffolds (foam 1 – 3) seeded with 
chondrocytes (-fibrin gel) or with chondrocytes in fibrin gel (+ fibrin gel) respectively. GAG was stained red 
with safranin-O.   
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Ear-shaped Cartilage Construct 
According to the results of the first experiments with OPF discs a variety of scaffold 
formulations was available for cartilage engineering without affecting the development of 
cartilaginous tissue. Foam 3 turned out to be best suited for the generation of the complex 3D 
structures of the human external ear and was chosen for the subsequent approach to engineer a 
cartilage construct in the shape of the human external ear.  The composition of foam 3 was 
foamed in the silicone mold and then seeded with chondrocytes suspended in fibrin gel. The 
combination with the fibrin gel was chosen due to a higher mechanical stability of the whole 
construct and a higher cell retention resulting in a higher seeding efficiency. 
After 28 days in culture an ear-shaped construct could be harvested, which under macroscopic 
examination had the appearance of cartilage (Fig. 18) and proved to be very elastic and 
mechanically stable during the harvesting procedure. During gross examination using forceps, 
it could be bent and folded up, which was completely reversible after removing the 
mechanical force with regaining its original shape After 28 days in culture the construct 
reached a wet weight of nearly 10 g.  
 
 
 
Figure 18: Ear-shaped OPF scaffold seeded with primary bovine chondrocytes in fibrin gel after 28 days in 
culture. Localization of the samples taken from representative section planes of the construct for biochemical 
and histological evaluation (1-7). 
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In order to gain an overview over the homogeneity of the development of cartilage tissue 
within the whole construct, samples of representative areas were taken (Fig 18 – right, section 
plane 1-7) and subjected to biochemical and histological examination. Wet weight slightly 
differed between the discs from the respective section planes, as the construct was not even, 
thus the thickness of the samples also varied (Fig 19A). Thus cell number was normalized to 
wet weight (Fig. 19B). Over the culture period substantial amounts of extracellular matrix 
components were produced as indicated by an average of 1.85 % of GAG content per wet 
weight and a collagen content per wet weight of 1.27% (Table 4) without large variations 
between the section planes analyzed (Fig. 19C,E). The activity in synthesizing matrix 
components expressed as GAG per cell (Fig. 19D) and collagen per cell (Fig. 19F), 
respectively, did not show large variations depending on the location of the sample and 
reached satisfying levels. The total amount of GAG and collagen in the whole construct was 
calculated considering the wet weight of the whole construct and the wet weight of the discs 
cut out of the construct for biochemical analysis (Table 3).  
 
 
 
Table 3: Summary of the biochemical analysis of the ear-shaped cartilage construct after 28 days in culture 
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Figure 19: Wet weight (A), cell number (B), GAG content (C,D) and collagen content (E,F) of samples taken 
from representative section planes of the construct as indicated in figure 18. 
 
In order to evaluate the distribution of GAG within the construct cross-sections from the 
different section planes were stained with safranin-O and fast green. All samples displayed an 
intense and almost homogenous red staining indicating matrix rich in cartilage specific GAG. 
The space between the pores filled with cartilage (red) was partially due to the cutting 
procedure during which the different parts were torn apart (Fig. 20). Only in section plane 2 
and 5, there were pores partially stained green, where fibrous tissue could be found. In section 
plane 5 there were some pores visible displaying green staining, a phenomenon which might 
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be due to air bubbles in the gel during the seeding procedure, i.e. the pores were incompletely 
filled with fibrin gel and suspended chondrocytes. 
 
Discussion 
 
In the first part of the study the general suitability of the OPF scaffolds for cartilage tissue 
engineering, also in combination with fibrin gel, was investigated as well as the impact of the 
formulation on tissue development. In contrast to the approach combining fibrin gel and 
polyurethane scaffolds (Chapter 3) in the investigation two hydrogels were combined. The 
comparison of cartilage tissue development in the three different OPF foams rendered no 
statistically significant difference between the OPF formulations. With each formulation a 
coherent cartilage tissue could be achieved (Fig. 17). Few single pores were not completely 
stained in the same intense red colour (Fig. 17 foam 1/ 2/ 3 + fibrin gel). This phenomenon 
was attributed to air bubbles in the gel during the seeding procedure, as this was only 
observed in the constructs seeded with chondrocytes in fibrin gel. The air in the fibrin gel 
apparently inhibited a complete filling of the respective pores with the gel containing the 
cells. Hence in this area less ECM could be detected. 
For further investigations foam 3 was chosen, as the three different OPF formulations showed 
no difference with regard to cartilage development (Figs. 16 & 17) and foam 3 turned out to 
be the best suited for the foaming process during the generation of scaffolds with a more 
complex structure. Thus, in the subsequent approach the formulation of foam 3 was foamed in 
a silicone mold, which had the shape of a human external ear. 
The combination of the scaffold with fibrin gel was chosen to guarantee mechanical stability 
and a high retention of cells during the seeding procedure and of the newly synthesized matrix 
during the culture period. Especially the latter advantage has already been shown for other 
systems like combining polyurethane scaffolds and fibrin gel [24]. 
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Figure 20: GAG distribution in cross-sections of samples taken from indicated sections planes of the ear-shaped 
cartilage construct after 28 days in culture. GAG was stained red with safranin-O.  
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After 28 days in culture, the ear-shaped construct had the typical appearance of cartilage and 
was elastic and resisted mechanical forces (bending, folding) during the harvesting procedure 
and gross examination using forceps. Biochemical analysis showed substantial amounts of 
ECM components throughout the construct (Fig. 19, Table 3). Histological evaluation 
demonstrated a coherent cartilage tissue throughout the construct with a mainly homogenous 
and intense staining for GAG in cross-sections of the majority of discs that were punched out 
from representative parts of the scaffold (Fig. 20).  
Other groups also approached reconstruction of the external ear by tissue engineering [41, 48-
50] applying a variety of biomaterials (c.f. Chapter 3).  Liu et al. also applied CAD/ CAM and 
reported the only ear-shaped scaffold that had a detailed structure similar to one presented in 
this study.  However, none of the cited studies provided a comprehensive analysis of 
developed cartilage in the whole ear-shaped construct with spatial resolution. Consequently, 
investigation of homogeneity and coherence of the engineered cartilaginous tissue was not 
considered in these studies in contrast to the study presented here. 
In summary, here we successfully demonstrate the engineering of a proto-type of a very 
complex and custom-made ear-shaped cartilage construct. Samples taken from representative 
areas of the scaffold showed substantial accumulation of ECM (Fig. 20). Variation of the 
results of the biochemical evaluation of the construct depending on the location of the 
samples revealed the need to optimize the seeding procedure. After optimization of the 
seeding procedure and possibly also of the culture conditions, with respect to growth factor 
supplementation or dynamic cultivation further experiments have to be undertaken with 
human chondrocytes in order to proceed towards clinical application. Human, autologous 
cartilage implants of clinically relevant dimension also demand further research to solve the 
problem of cell source, i.e., the limited availability of autologous chondrocytes. Methods to 
expand cells under conservation of their cartilaginous phenotype or options for 
redifferentiation after expansion in a 2-dimensional environment, which easily leads to rapid 
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dedifferentiation [60], are to be investigated. As an alternative, chondrogenically 
differentiated mesenchymal progenitor cells may be utilized (see also Chapter 8). 
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Introduction 
 
Osteochondral defects affect the articular cartilage but also the underlying subchondral bone 
of the joint. They are usually caused by trauma or osteochondritis dissecans. Osteochondral 
defects often cause mechanical instability of the joint and are therefore associated with the 
risk to induce osteoarthritic degenerative disease. To date a widely accepted treatment 
procedure for osteochondral defects is still missing [61]. Although in clinical use autologous 
osteochondral constructs turned out to be promising, they are accompanied by several 
limitations. Tissue engineering of osteochondral grafts allows the generation of individually 
tailored constructs of defined dimension and shape [62]. Furthermore co-culture is a powerful 
tool to study cellular interactions [63]. 
There are several strategies to engineer osteochondral constructs. Concerning the applied 
scaffold one option is to use a scaffold for the bone part in combination with a scaffold-free 
cartilage-part. Moreover different scaffolds for bone and for cartilage are chosen and 
combined at the time of implantation. In case of applying a single scaffold two approaches are 
possible, either the application of a single heterogeneous, bilayered or of a single homogenous 
scaffold for both, the bone and the cartilage component. The choice of the cell source also 
implies a variety of options. Scaffolds can be loaded with a single cell source having 
chondrogenic capacity or with two cell sources having either chondrogenic or osteogenic 
potential. Another possibility is the application of cells which have both, chondrogenic as 
well as osteogenic differentiation capacity. Cell-free scaffolds have also been employed [62]. 
A wide range of materials is available for scaffolds used for osteochondral grafts, biological 
and synthetic materials. Perichondrium, alginate, chitosan, periost, DBM (demineralised bone 
matrix) and allogenic/ xenogenic bone serve as examples for biological materials. These 
materials facilitate tissue development as they comprise good osteoinductive as well as 
biomechanical properties. DBM for instance contains growth factors and supports osteogenic 
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differentiation. Synthetic materials applied include PLA (polylactic acid), PLGA (polylactic – 
co- glycolic acid), PU (polyurethane), CDHA (calcium-deficient hydroxyapatite), β-TCP 
(tricalciumphosphate).  Ceramics like hydroxyapatite or β-TCP consist of minerals of the 
natural bone matrix [64]. 
Within a joint project (‘Regenerative Implants’, Bavarian Research Foundation ‘Bayerische 
Forschungstiftung’) involving several research groups and companies, our group was 
responsible for the chondrogenic culture within an osteochondral construct. In order to yield 
an optimal environment for the respective cell type, well established scaffold-materials were 
chosen for the bone as well as for the cartilage component and combined in a single, bilayered 
scaffold. Biphasic scaffolds for osteochondral grafts have been proposed by various groups 
[65–68]. To engineer the cartilage part the established concept of seeding chondrocytes 
suspended in long-term stable fibrin gels in PU scaffolds [24] was chosen. For the bone part a 
hydroxyapatite–based scaffold was prepared by dispense-plotting a special rapid prototyping 
method. Hydroxyapatite-based scaffolds were already successfully used for bone tissue 
engineering approaches [69]. In order to obtain a single, bilayered scaffold the hydroxyapatite 
based composite was directly plotted on the polyurethane scaffold. The PU-part was seeded 
with chondrocytes in fibrin gel. After pre-culture for one week the composite-part was seeded 
with GFP-labelled human BMSC. In the first part of the study a method for selective seeding 
of the cartilaginous part had to be established. The following experiments were conducted 
applying both cell types to investigate their compatibility and cell distribution to evaluate the 
potential of the system for generation of osteochondral grafts for a longer culture period in a 
bioreactor.  
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Results 
 
Establishment of a Selective Seeding Procedure 
To reach a selective seeding of the polyurethane (PU)-part of the bilayered scaffold consisting 
of a PU-part for the development of cartilage tissue and a composite-part plotted directly on 
the surface of the PU scaffold for engineering bone, a method to radially insert the fibrin gel 
with the chondrocytes into the scaffold was established (c.f. Chapter 2 “Materials and 
Methods”, Fig. 3). Two different types of bilayered scaffold were employed. The first type 
was characterized by a membrane separating PU- and composite-part (“with membrane”). 
The membrane was introduced during the production process of the PU scaffold and the 
composite was later plotted directly on the membrane. The second type was produced without 
the separating membrane (“open”). In this case the composite was directly plotted on the open 
pores of the PU scaffold and the development of a membrane was inhibited to a certain extent 
during the fabrication of the PU scaffold. 
The application of a cell-free fibrin gel stained with bromophenolblue permitted a first 
estimation of the success in selective insertion of the fibrin gel into the PU-part (Fig. 21). The 
images of the constructs with stained fibrin gel taken with the stereo-magnifier demonstrated 
an evenly blue stained PU-part and a composite-part, which remained mainly unaffected by 
the blue fibrin gel.  
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Figure 21: Selectivity of gel insertion into bilayered scaffolds visualized by addition of bromophenolblue to the 
fibrin gel. Two batches of scaffolds were investigated. Two different types can be distinguished. I, II represent 
scaffolds, which were produced by plotting the composite part on the membrane covering the PU scaffold (“with 
membrane”), whereas in case of II o the composite-part was plotted on the scaffold on open pores (“open”). 
 
 
For a first cell culture experiment, bovine chondrocytes suspended in fibrin gel were seeded 
in the PU-part. After 21 days cultured in vitro, the ratio of chondrocytes in the PU-part and in 
the composite-part was determined (Fig. 22A). The majority of the cells could be detected in 
the PU-part, thus a certain degree of selectivity could be realized, however, for a co-culture 
the number of chondrocytes in the composite-part, supposed for the GFP-labelled hBMSC, 
had to be reduced. The cell number per wet weight (Fig. 22B) was also determined, but was 
of minor value due to the differences concerning the weight of the scaffold material. 
Unexpectedly, the membrane between the two scaffold parts did also not favour selectivity 
during the seeding procedure (Fig. 22A). Considering the activity of the chondrocytes 
concerning production of extracellular matrix (ECM) components, i.e., glycosaminoglycans 
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(GAG) (Fig. 22C) and collagen (Fig. 22D), no difference between both types of bilayered 
scaffolds (“with membrane” and “open”) could be detected.  
 
 
 
Figure 22: Biochemical analysis of bilayered scaffold, seeded with bovine chondrocytes in fibrin gel selectively 
in the PU-part of the scaffold, after 21 days in culture. Selectivity was analyzed by calculating the ratio of 
chondrocytes in the PU-part and in the composite-part (A). Matrix production was analyzed by determination of 
GAG- (C) and collagen – (D) production. Data represents the average ± SD of three independent constructs.  
 
Homogeneity of GAG distribution in the PU-part and possible undesirable and unintended 
matrix in the composite part was analyzed by safranin-O staining of cross-sections after 21 
days in culture (Fig. 23). Regarding the stained cross-sections, in the area of the composite 
part an intense and homogeneous safranin-O staining indicated a coherent cartilage matrix in 
the part of the construct intended for the bone-part. This was the case in both experimental 
groups. In the PU-part intense red staining of GAG indicated production of substantial 
cartilage tissue in both groups. The empty space between the pores may be due to the cutting 
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process during sample preparation. The pictures of the transition zone in both groups also 
displayed ECM accumulation particularly towards the composite part, which is the lower 
layer in the images. 
 
 
 
Figure 23: Glycosaminoglycan (GAG) distribution in cross-sections of bilayered scaffolds after 21 days in 
culture. Safranin-O stained GAG red.  
 
Thus, histological evaluation also showed that there was no difference between the two types 
of bilayered scaffolds and substantial amounts of chondrocytes and consequently also of 
produced extracellular matrix could be detected in the composite part. Histological 
examination also documented that the membrane did not enhance selectivity of the seeding 
procedure. 
A first real co-culture resulted in similar findings. After one week of pre-cultivation of the 
constructs with chondrocytes in the PU-part, the composite-part was seeded with GFP-
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labelled hBMSC and co-cultured for 3 days to evaluate compatibility. DAPI (2-(4-
amidinophenyl)-1H indole-6-carboxamidine) staining was conducted to analyze distribution 
of chondrocytes (blue fluorescence) and GFP-labelled hBMSC (green fluorescence) in the 
cross-section. A considerable number of chondrocytes could be detected by blue fluorescence 
in the composite-part (Fig. 24A).  The live-dead-assay displayed many fluorescing cells 
particularly in the PU-part of the bilayered scaffold indicating a high amount of dead cells 
(Fig. 24B). 
 
 
 
Figure 24: After pre-cultivation for 1 week and subsequent seeding with GFP-labelled hMSC (green 
fluorescence) cross-sections were stained with DAPI to visualize distribution of chondrocytes (blue 
fluorescence) and GFP-labelled hBMSC (green fluorescence) (left). Viability of chondrocytes was investigated 
by live-dead assay with propidium iodide (red fluorescence of dead cells) and fluorescein-diacetate (green 
fluorescence of viable cells) (right). (Seeding with hBMSC, co-culture and staining was conducted by Dr. I. 
Drosse, research group Prof. M.Schieker, LMU, Munich, Germany.) 
 
In order to overcome the problem of reduced viability the height of the PU-part was reduced 
from 4 mm to 2 mm. The initial cell density seeded into the PU-part was reduced to half of 
the amount applied in the first experiment and the volume of gel inserted was additionally 
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reduced to 80% of the volume of the PU-scaffold part, i.e., the calculated initial number of 
chondrocytes seeded per construct amounted to 3.7*106 cells.  Cell distribution was analyzed 
24 hours after seeding, on day 3 and day 8 to explore, if the high number of chondrocytes 
located in the composite-part was due to little selectivity during the seeding procedure or due 
to cell migration.  
 
 
 
 
Figure 25: Selectivity of the seeding procedure and cell distribution during a culture period of 8 days (intended 
pre-cultivation time till seeding with GFP-labelled hBMSC) determined by DNA assay (A, B). Matrix 
production of the cells in the different parts of the bilayered scaffolds was analyzed by GAG assay from day 1 up 
to day 8 (C, D). Data represents the average of three independent constructs ± SD with the exception of day 3, 
which was only represented by 2 constructs. 
 
24 hours after seeding the bilayered scaffolds, approximately 20 % of the total cell number 
could be detected in the composite part (Fig. 25A), consequently the seeding procedure had to 
be declared as preferential, but not as selective as intended. Up to day 8 the ratio of 
chondrocytes in the composite-part increased to almost 50%. In both parts of the bilayered 
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scaffold GAG was deposited (Fig. 25C) and GAG production per cell was similar in both 
parts of the bilayered scaffold (Fig. 25D).  
 
 
 
Figure 26: Selectivity of seeding the PU-part of the bilayered scaffold, while the composite part was blocked 
with a thermo-reversible gelatine gel. In case of the constructs “with membrane” the composite was plotted on 
the membrane covering the surface of the PU scaffold. The other variant indicated by “open” implied a PU-part 
without a membrane on the surface, thus, the composite was plotted on the open pores of the PU disc. Data 
represents the average of three independent constructs ± SD.  
 
As the results described above were not satisfying for the intended purpose due to deficits in 
selectivity, the effect of blocking the composite-part with a thermo-reversible gelatine gel 
during the seeding procedure was investigated (c.f. Chapter 2). Blocking the composite-part 
with the thermo-reversible gelatine gel yielded a highly selective seeding of exclusively the 
PU-part of the bilayered scaffold using the scaffolds with (“with membrane”) and without 
(“open”) a membrane between PU- and composite-part (Fig. 26). After 24 hours the ratio of 
chondrocytes in the composite-part accounted for 2.4% in the scaffolds with membrane and 
5.9% in the scaffolds with the composite plotted on the PU-part without a membrane. Thus, 
remarkable increase in selectivity could be reached applying the thermo-reversible gelatine 
gel with little difference between the two types of bilayered scaffolds. Also after 7 days in 
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culture, only a negligible amount of chondrocytes was detected in the composite part (3.7%) 
(Fig. 26).  
In order to gain an impression of the interconnectivity of the PU-part of the different 
scaffolds, which is crucial for providing nutrients, scanning electron microscopy was 
conducted. The PU scaffold with membrane was characterized by very small pores without 
interconnections between the pores (Fig. 27).  
 
 
 
Figure 27: SEM images taken from the PU-part of the bilayered scaffolds to show the difference of pore size 
and interconnectivity between PU scaffold with a membrane on the surface (“with membrane”) or without a 
membrane (“open”). 
 
Due to the fact that the production of a membrane on the surface of the PU scaffold during the 
foaming process resulted in a very low interconnectivity and small pores, this variant was 
regarded as inappropriate for further application in chondrocyte cell culture. Moreover, the 
membrane did not promote selectivity in the seeding procedure of the bilayered scaffolds. 
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Consequently, for the following co-culture experiment bilayered scaffolds without a 
membrane were selected. 
 
 
 
Figure 28: DAPI staining (blue fluorescence of nuclei) of the cross-sections of the bilayered scaffold seeded 
with chondrocytes and after 7 days pre-cultivation with GFP-labelled hBMSC (green fluorescence) was 
conducted to visualize the distribution of the two cell types in the two parts of the scaffold as well as in the 
transition zone after 3 days of co-culture. A live-dead-assay was also performed to test viability of the cells in 
the different parts of the construct after 3 days of co-culture. Living cells appear green (staining with fluorescein-
diacetate) and dead cells were stained with propidium iodide (red). (Seeding with hBMSC, co-culture and 
staining were conducted by Dr. I. Drosse, research group Prof. M.Schieker, LMU, Munich, Germany.) 
 
In a second co-culture experiment, chondrocytes were suspended in fibrin gel and seeded into 
the PU-part using the optimized seeding method, i.e., after blocking the composite part with 
the thermo-reversible gelatine gel. Constructs were pre-cultured for 7 days and then were 
seeded with GFP-labelled hBMSC. After a short culture of 3 days cell distribution and 
viability were investigated. The cross-sections stained with DAPI showed that some green-
fluorescent hBMSC could be found in the PU-part and a small amount of blue-fluorescent 
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chondrocytes could be detected in the composite-part (Fig. 28). The DAPI staining clearly 
demonstrated an increase in selectivity compared to the first co-culture (Fig. 24 & Fig. 28). 
Cross-sections of the bilayered constructs stained with propidium-iodide and fluorescein-
diacetate revealed some dead cells in the bilayered construct particularly in the PU-part (Fig. 
28). 
 
Discussion 
 
The engineering of osteochondral constructs was approached employing bilayered scaffolds 
with two different parts intended for cartilage and bone engineering, respectively. A method 
to selectively seed the PU-part of the bilayered scaffolds with chondrocytes could be 
established. The ratio of chondrocytes detectable after 24 hours in the composite-part could be 
reduced by temporary application of a thermo-reversible gelatine gel from 20% (Fig. 25A) to 
2.4% with membrane and 5.9% (Fig. 26) without a membrane between the PU- and the 
composite-part. 
The large increase in selectivity yielded by temporary blockage of the composite was also 
apparent in the cross-sections of the bilayered scaffold stained with DAPI after 3 days of real 
co-culture of chondrocytes and hBMSC (Fig. 28). Only a small number of blue fluorescent 
cells, i.e. of chondrocytes, was detected in the composite part. The scaffold without a 
membrane between the two different parts yielded results very similar to the membrane 
containing scaffolds, i.e., the membrane on the surface of the PU-part, which originally was 
supposed to increase selectivity and to inhibit cell migration, did not additionally favour 
selectivity, when blocking the composite-part with the thermo-reversible gelatine gel during 
the seeding procedure (Fig. 26).  
This was advantageous as the generation of the membrane during the production process of 
the PU scaffold was associated with decreasing pore-size and interconnectivity (Fig. 27). 
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Interconnectivity and a certain dimension of the pore, in turn are vital for nutritive supply of 
the cells inside the scaffold and, thus, for tissue development [51].  
Comparing the expansion of the number of chondrocytes in the composite part without 
temporary blockage of the composite part (Fig. 26A) with the very low increase from day 1 to 
day 7, when the composite part was blocked with the thermo-reversible gelatine gel (Fig. 26), 
the high increase of cells in the composite part is probably ascribable to proliferation not to 
migration of the cells.  
A similar concept with regard to scaffold design for osteochondral constructs was chosen by 
Schek et al. Two bonded cylinders were used to form a bilayered scaffold comprising a 
cylinder of hydroxyapatite (HA) and another one of poly-L-lactic acid (PLA). In order to 
inhibit infiltration during seeding and cell migration during culture a thin polyglycolic acid 
(PGA) film coated the poly (lactide acid) (PLA) cylinder. The seeding was conducted in two 
steps. First bone morphogenetic protein-7 (BMP-7) transfected human gingival fibroblasts 
suspended in a fibrinogen solution were seeded onto the HA-part and immediately placed on a 
drop of thrombin solution to start gelation. Then the PLA-part was seeded with chondrocytes. 
In this study, the centre of the polymer-part also displayed only a low safranin-O staining. 
Cartilage tissue could also be found in the HA-cylinder indicating that the PGA barrier failed 
to prevent infiltration of the ceramic part by chondrocytes. The PGA film was also supposed 
to be the reason for deficits in the development of the interface as it also inhibited interaction 
of osteoblasts and chondrocytes. Mineralized cartilage however could be detected at the 
interface [70].  
Towards the successful engineering of osteochondral constructs, further experiments with a 
longer co-culture-period have to be conducted to evaluate development of coherent cartilage, 
bone and a bone-cartilage interface. In order to improve the nutritive situation in the 
polymeric part of the bilayered scaffolds a higher degree of interconnectivity would be 
advantageous. Culture conditions may be improved by the use of bioreactors that can provide 
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controlled medium flow and can impose mechanical load [71]. For example, it has been 
shown that cyclic hydrostatic pressure can enhance chondrogenic matrix production of human 
mesenchymal progenitors differentiated in vitro. These results also suggested that mechanical 
loading might play a vital role in cartilage development [72]. In order to provide optimal 
conditions for co-culture two-chamber bioreactors may be advantageous [73]. 
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Introduction 
 
Cartilage tissue engineering is a promising approach as a treatment for cartilage defects in the 
joint [5, 13], but also in craniofacial surgery, e.g., for auricular reconstruction [37, 41]. One of 
the great challenges in this field is to overcome the limitations concerning the amount of 
autologous harvestable chondrocytes. One possibility is to expand the chondrocytes in 2-
dimensional (2D) environment before culture on a 3-dimensional (3D) cell carrier. Expansion 
in 2D, however, is accompanied by rapid dedifferentiation, associated with. for example, 
predominant expression of type I collagen [60] rendering the chondrocytes less suitable for 
cartilage tissue engineering purposes [5, 74]. Thus, growth factors are applied either already 
during expansion of the chondrocytes [75–78] or during subsequent 3D culture [75, 78–80] to 
improve the quality of the generated tissue.  
Studies conducted in the group demonstrated synergistic effects of the protein growth and 
differentiation factor-5 (GDF-5) in combination with insulin, on bovine chondrocytes on poly 
(glycolic acid) (PGA) scaffolds. GDF-5 belongs to the bone morphogenetic protein (BMP) 
subfamily. BMPs are members of the transforming growth factor-β superfamily and were 
identified as inducers of bone and cartilage formation in vivo [81]. GDF-5 or cartilage derived 
morphogenetic protein-1 (CDMP-1), which is used synonymously, is a growth factor 
involved in limb formation [82–84] and appears also in the stage of mesenchymal 
condensation and throughout the cartilaginous cores of the developing long bones of bovine 
embryos [85]. GDF-5 has also been postulated to be involved in the maintenance of healthy 
cartilage and regenerative response in diseased tissue as it was found in the superficial layer 
of normal cartilage and throughout osteoarthritic cartilage [86]. Insulin has previously been 
shown to have distinct anabolic effects on engineered cartilaginous constructs from primary 
cells similar to those of insulin-like growth factor-I (IGF-I) [27, 87].   
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In the preceding study mentioned above the effects of GDF-5 either alone or in combination 
with insulin were investigated. In case of primary chondrocytes, the application of GDF-5 
combined with insulin resulted in an increase of wet weight and cell number without affecting 
the production of glycosaminoglycans (GAG) and collagen per cell. When the clinically more 
relevant expanded chondrocytes were used, supplementation with GDF-5 or insulin alone led 
to only very small constructs. However, supplementation with the combination of GDF-5 
(0.01 and 0.1µg/ml) and insulin (2.5 µg/ml) during cartilage development affected the 
engineered made from expanded chondrocytes in a synergistic manner, leading to 
substantially increased production of cartilaginous extracellular matrix [88, 89].  
In the studies presented here the impact of the application of GDF-5 alone or in combination 
with insulin already during chondrocytes expansion was investigated with bovine 
chondrocytes in fibrin gels as 3D cultures system [23]. Furthermore, the transferability of the 
results obtained with expanded juvenile bovine chondrocytes in PGA scaffolds to expand 
adult human chondrocytes in PGA scaffolds to expand adult human chondrocytes in a 3D 
pellet culture system, which has also been previously successfully employer for cartilage 
engineering [90, 91]. By using different culture systems, also independency of the synergism 
from the chosen 3D system could be examined. In a last preliminary experiment, the effect of 
GDF-5 or insulin, either alone or in combination, on adipose-derived stem cells was 
investigated in pellet culture, as adipose-derived stem cells represent an attractive alternative 
cell source for cartilage tissue engineering applications (see also Chapter 8). 
 
Results 
 
Effect of GDF-5 or GDF-5 in Combination with Insulin Applied during Expansion 
In the first part of the study of GDF-5 (0.1 µg/ml) (G 0.1) alone or in combination with 
insulin (2.5 µg/ml) (G 0.1 +I) was applied during the expansion of bovine chondrocytes and 
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the effect on tissue quality yielded during expansion of bovine chondrocytes and the effect on 
tissue quality yielded during subsequent 3D culture in fibrin on tissue quality yielded during 
subsequent 3D culture in fibrin gel was investigates. The concentration of the protein was 
based on previous studies [88].  Fibrin gel culture was also conducted under three different 
conditions, i.e., control conditions without supplementation, supplementation with GDF-5 (G 
0.1) alone or in combination with insulin (G 0.1+I). A flow chart showing the experimental 
design is given in Chapter 2 (Fig. 3). After 21 days in fibrin gel culture the groups which 
received the combination of GDF-5 and insulin displayed the typical appearance of cartilage 
and retained the initial construct size of 5 mm in diameter.  
 
 
 
Figure 29: Macroscopic appearance of fibrin gels seeded with expanded (P2) bovine chondrocytes after 21 days 
in culture without factor supplementation (CTR), supplementation with GDF-5 at a concentration of 0.1µg/ml (G 
0.1) or the combination of GDF-5 (0.1µg/ml) and insulin (2.5µg/ml) (G 0.1+I). Before seeding, cells were 
expanded under different conditions. Exp: CTR: expansion without supplementation; Exp: G 0.1: expansion with 
GDF-5 supplementation of 0.1 µg/ml; Exp: G-0.1 +I: expansion with supplementation with the combination of 
GDF-5 (0.1 µg/ml) and insulin (2.5 µg/ml).  
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The constructs were mechanically stable suggesting the production of substantial amount of 
extracellular matrix (ECM). In this group there was no obvious difference between the 
different expansion conditions.  
Fibrin gels cultured under control conditions or under supplementation with GDF-5 alone 
(0.1µg/ml) decreased dramatically in size and were red in colour indicating high diffusion of 
medium and low amount of cartilaginous ECM (Fig. 29). This was consistent with the 
mechanical instability of the constructs, which were soft and gel-like. In these two groups 
there was also no difference apparent between the different expansion conditions. 
Biochemical analysis displayed a much higher wet weight (approximately 10 – to 20-fold 
higher wet weight) of the constructs cultured under supplementation with the combination of 
GDF-5 and insulin, compared to culture without supplementation with the combination of 
GDF-5 and insulin, compared to culture without supplementation or with addition of GDF-5 
alone (Fig. 30A). The same applied to the absolute cell number per construct, which was 
approximately 10-fold higher in the combination group as in the control (CTR) and in the 
GDF-5 (G 0.1) group (Fig. 30B). GAG was hardly detectable in the control groups as well as 
in the GDF-5 (G 0.1) groups irrespective of the expansion conditions. In contrast, the groups 
cultured under GDF-5 and insulin supplementation (0.1+I) displayed substantial amounts of 
GAG (Fig. 30C). 
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Figure 30: Wet weight (A) cell number (B), glycosaminoglycan (GAG) (C) content, and collagen content (D) of 
fibrin gel constructs after 21 days of culture. Fibrin gels were seeded with passage 2 chondrocytes expanded 
under different conditions: control (Exp.: CTR), GDF-5 (0.1 µg/ml) (Exp: G 0.1) supplementation or addition of 
the combination of GDF-5 (0.1 µg/ml) and insulin (2.5 µg/ml). Fibrin gels were cultured under the following 
conditions: control (CTR), GDF-5 supplementation (0.1 µg/ml) (G 0.1) or addition of GDF-5 (0.1 µg/ml) and 
insulin (2.5 µg/ml) (G 0.1 +I). Data represents the average ± SD of three independent constructs. Statistically 
significant differences between the groups are denoted by symbol (○) (p < 0.05) or asterisk (*) (p<0.01).  Before 
analysis normality test was conducted. In case of failure (indicated by 1) Kruskal Wallis analysis of variance on 
ranks with subsequent Tukey test was performed.  
 
Comparing, for example, constructs seeded with cells expanded under control conditions 
(Exp: CTR) and cultured in 3D in CCM without further supplements (Exp. CTR – CTR) with 
constructs applying cells expanded also under control conditions (Exp: CTR), but cultured 
with GDF-5 and insulin supplementation in fibrin gel culture (Exp. CTR – G 0.1+I), the latter 
one showed the 8-fold GAG content per wet weight compared to control constructs (Exp: 
CTR-CTR).  Comparing matrix production within the group receiving the factor combination 
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during 3D culture, the preceding expansion under control conditions turned out to be more 
favourable than expansion under GDF-5 (Exp.: G 0,1) supplementation or addition of the 
combination of both proteins, GDF-5 and insulin (Exp. G 0.1+I) (Fig. 30). Considering the 
collagen content, the groups did not defer much with regard to collagen per wet weight (Fig. 
30 D). 
GAG distribution was analyzed by staining cross-sections of the fibrin gel constructs with 
safranin-O (Fig. 31). Only the constructs which received CCM supplemented with the 
combination of GDF-5 and insulin (G 0.1+I) during fibrin culture displayed homogenous and 
intense red staining indicating substantial amounts of GAG throughout the whole construct. 
Constructs, cultured either in CCM without supplements or GDF-5 supplementation alone 
were stained green, indicating the dominance of fibrous tissue and the absence of GAG. 
Comparing the sub-groups of the group, which was cultured with CCM supplemented with 
the combination of the proteins during 3D culture (G 0.1 +I), the most intense and 
homogeneous red staining could be detected in the cross-sections of the fibrin gels seeded 
with passage 2 chondrocytes expanded under control conditions (Exp: CTR).  
Biochemical as well as histological evaluation of the constructs showed no beneficial effect of 
applying GDF-5 alone or in combination with insulin during the expansion of the 
chondrocytes on tissue quality attainable during subsequent 3D culture.  
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Figure 31: Glycosaminoglycan (GAG) distribution in cross-sections of fibrin gels seeded with passage 2 
chondrocytes after 21 days in culture. GAG stained red with safranin-O. The columns divide the different 
conditions during 3D culture in fibrin gel: control (CTR), with GDF-5 (0.1µg/ml) (G 0.1) supplementation or 
addition of GDF-5 (0.1 µg/ml) combined with insulin (2.5 µg/ml) (G 0.1+I). The first row shows constructs 
seeded with passage 2 (P2) chondrocytes expanded under control conditions (Exp: CTR), the second one with P2 
chondrocytes expanded under GDF-5 supplementation (0.1 µg/ml; Exp: G 0.1), the last row with P2 
chondrocytes expanded under supplementation with GDF-5 (0.1 µg/ml) and insulin (2.5 µg/ml) (Exp: G 0.1+I). 
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Synergistic Effect of GDF-5 and Insulin on Expanded (P2) Human Chondrocytes 
In order to investigate the possible clinical relevance of the combination of GDF-5 and insulin  
the effect of insulin (2.5 µg/ml) (I 2.5) and GDF-5 (0.1 µg/ml) alone or in combination (G 
0.1+I) on tissue quality yielded with expanded (passage 2) adult human chondrocytes was 
studied in a pellet culture system. 
  
 
 
Figure 32: Cross-sections of pellets generated with human passage 2 chondrocytes after 3 weeks of culture. 
Distribution of glycosaminoglycans (GAG) (A), GAG was stained red with safranin-O. Type I collagen (B) and 
type II collagen (C) distribution, collagens were immunohistochemically stained employing type I and type II 
collagens antibody respectively (brown stain).  
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The study with human adult passage 2 chondrocytes rendered similar results as obtained with 
expanded bovine chondrocytes. Application of proteins resulted in increased pellet size as 
compared to controls. Control pellets and pellets receiving single proteins exhibited a 
homogeneous, but weak safranin-O staining for GAG (Fig. 32A). The combination of GDF-5 
and insulin resulted in a distinctly stronger staining for GAG in large areas of the pellet.  
Control constructs were stained positive for type I collagen (Fig. 32B). Constructs cultured 
under supplementation with insulin (2.5 µg/ml) (I 2.5) or GDF-5 (0.1 µg/ml) (G 0.1) also 
displayed a positive staining for type I collagen staining, however, was less intense compared 
to the control group. The combined application of GDF-5 and insulin resulted in a distinctly 
lighter staining for type I collagen compared to the other experimental groups. 
Complementary results were observed by type II collagen immunohistochemical staining. 
Neither control constructs nor constructs receiving either insulin or GDF-5 alone showed the 
presence of type II collagen. In clear contrast, under the supplementation with the 
combination of GDF-5 and insulin (G 0.1+I), a strong type II collagen staining was detected. 
The results obtained by quantitative real-time RT-PCR were consistent with the histological 
and immunohistochemical staining. Type I collagen mRNA was upregulated by insulin, as 
compared to controls (3.6-fold), whereas it was not affected by GDF-5 applied alone or in 
combination with insulin (Fig. 33A). In contrast, application of insulin alone led to a distinct 
down-regulation of type II collagen mRNA expression compared to control (33-fold), and the 
combination of GDF-5 and insulin resulted in a tremendous up-regulation of type II collagen 
(115-fold, Fig. 33B). 
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Figure 33: Relative quantification using RT-PCR of type I (A) and type II (B) collagen mRNA expression on 
day 21 of pellet culture with human passage 2 chondrocytes. Data represents the average of two or three 
independent constructs, error bars indicate the minimum and the maximum values. Expression levels of target 
genes were normalized to the expression of GAPDH serving as housekeeping gene. Expression levels were 
further normalized to expression levels of the control samples (set as 100%).  
 
Effect of GDF-5 and Insulin on Chondrogenic Differentiation of Human Adipose Tissue 
Derived Stem Cells (ASC) 
In a last, preliminary experiment the effect of GDF-5 and insulin alone or in combination on 
chondrogenic differentiation was examined. The application of GDF-5 (0.1 µg/ml) (G 0.1) or 
insulin (2.5 µg/ml) alone or in combination did not exert an effect on cell number after 21 
days in pellet culture (Fig. 34A). Supplementation of CCM with either factor alone or in 
combination yielded a higher GAG production per cell compared to the control without factor 
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supplementation (Fig. 34B). Highest increase in GAG production per cell could be achieved 
applying GDF-5 alone at 0.1 µg/ml (approximately 3-fold higher production in the GDF-5 
group compared to control). Substantial amounts of GAG, however, could not be detected. In 
accordance to the results of the biochemical analysis, the histology did not show a 
considerable red staining of the cross-sections of the pellets, indicating no sufficient GAG 
production. Cross-sections displayed green colour which demonstrated the development of 
fibrous tissue. Only around few cells a faint red corona could be detected, particularly in the 
group which received supplementation with GDF-5 and insulin (G 0.1+I) (Fig. 35).  
 
 
 
Figure 34: Cell number (A) and GAG content (B) of ASC pellets after 21 days in culture. Pellets were either 
cultured under control conditions (CTR), in CCM supplemented with GDF-5 (0.1µg/ml) (G 0.1) or with insulin 
(2.5 µg/ml) (I 2.5) alone or with supplementation with the combination of both proteins (G 0.1 +I). For each 
group 3 individual pellets were pooled. GAG [ng]/ cell as well as GAG [µg]/ DNA [µg] are shown here for 
better comparison with literature (c.f. discussion). 
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Figure 35: Cross-sections of pellets with ASC after 21 days in culture. Pellets were cultured under control 
conditions (CTR), with GDF-5 (0.1 µg/ml) (G 0.1) or insulin (2.5 µg/ml) (I 2.5) supplementation or the 
combination of both GDF-5 and insulin (G 0.1 +I) was added to CCM. Cross-sections were stained with 
safranin-O, which stains glycosaminoglycans red.  
 
 
Discussion 
 
GDF-5 is known to play an essential role in embryonic chondrogenesis and limb formation 
[81, 92, 93]. There is evidence that GDF-5 takes part in the complex cascade of bone fracture 
healing, for example by playing a central role in chondrogenesis and maturation of 
chondrocytes [94–96]. In adult bovine and human cartilage, GDF-5 was found to be 
expressed in both normal and osteoarthritic tissue [79]. However, the specific functions of 
GDF-5 in adult cartilage are still to be elucidated. Nevertheless, GDF-5 represents an 
interesting candidate molecule for cartilage engineering applications, as suggested in several 
studies using different in vitro and in vivo models [97–100].    
Engineering cartilaginous constructs, the use of in vitro expanded chondrocytes is still one of 
the major obstacles. In order to improve constructs made from passaged chondrocytes, 
different approaches have employed various growth factors. The synergistic effect of GDF-5 
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and insulin exerted on expanded (passage 2) bovine chondrocytes had previously been proven 
in the group [88, 89]. The experiments presented here were conducted applying GDF-5 and 
insulin in the concentrations which had turned out to be most effective [27, 88, 89]. 
In the first study, GDF-5 alone or in combination with insulin was applied during expansion 
of bovine chondrocytes and the effects on tissue quality attainable in subsequent 3D fibrin gel 
culture employing the differently expanded (passage 2) chondrocytes were investigated. The 
fact that the application of GDF-5 alone or in combination in the expansion phase with insulin 
did not exert a positive effect on subsequent development of cartilaginous tissue in fibrin gel 
(Figs. 30 & 31) could be considered as a clue towards the mechanism of action of these 
proteins. They seemed not to be able to inhibit dedifferentiation, but to have a favourable 
impact on redifferentiation processes occurring during 3D culture. For other growth factors, 
differential results were found. For example, the application of FGF-2 during expansion of 
bovine articular chondrocytes resulted in a reduced expression of fibroblast markers and a 
higher responsiveness to BMP-2 applied during PGA culture. The application of BMP-2 
during expansion in 2D, however, did not exert this positive effect [78], similar to the results 
observed in our study employing GDF-5 also being a member of the BMP-family. Jakob et al. 
also investigated the effect of several proteins applied during expansion (i.e., EGF, FGF-2, 
TGF-β1, PDGFbb, TGF-β1/ FGF-2). All used factors increased dedifferentiation as well as 
cell proliferation, but only FGF-2, EGF and PDGFbb application during expansion in 2D 
resulted in increased redifferentiation in pellet culture [75].  
The results previously obtained with juvenile bovine cells [88, 89] were supported by 
experiments employing adult human chondrocytes: Again, only the combination of GDF-5 
and insulin led to type II collagen expression, as detected by immunohistochemistry, at the 
same time reducing expression of type I collagen, compared to either factor alone (Fig.32). 
Type II collagen expression was also dramatically upregulated for the combination at the 
mRNA level (Fig. 33). Whereas no other studies on passaged chondrocytes are currently 
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available, previously, it has been reported that GDF-5 stimulated the ECM response of fetal 
rat calvarial cells towards the chondrogenic phenotype [101]. Interestingly, supplementation 
of GDF-5 alone led to only a slight upregulation of type II collagen expression and had no 
effect on type I collagen in mesenchymal stem cells, whereas a combination of GDF-5 and 
TGF-β1 distinctly increased type II collagen and reduced type I collagen expression [102]. In 
accordance to the previous studies with bovine chondrocytes[88, 89], in the presented study 
neither factor alone was able to overcome the dedifferentiation resulting from chondrocyte 
expansion; however, the combination of GDF-5 and insulin led to cartilaginous constructs 
with cells more actively producing ECM, and with a distinctly improved collagen subtype 
content. The demonstration of the synergistic redifferentiating effects of GDF-5 and insulin 
also for adult human chondrocytes further adds to the clinical relevance of the findings 
concerning the synergistic effect of GDF-5 and insulin. 
Various 3D culture systems were chosen for the investigation of the synergistic effects of 
GDF-5 and insulin. In previous studies, where the synergistic effects were described for 
expanded bovine chondrocytes, PGA scaffolds were applied [88, 89]. In fibrin gel culture as 
well as in the pellet culture system, the 3D culture systems used in the study presented here, 
synergistic effects of GDF-5 and insulin were also exerted on expanded bovine and human 
chondrocytes. The synergistic effects of GDF-5 and insulin are thus independent from the 
chosen 3D system. 
Due to the convincing results with expanded human adult chondrocytes the question arose, if 
besides a synergistic effect during redifferentiation of dedifferentiated chondrocytes a 
synergistic effect during chondrogenic differentiation of human mesenchymal is also exerted 
by GDF-5 and insulin. Human adipose derived stem cells were chosen, as they are 
characterized by an easy availability with little burden for the patient, the possibility to obtain 
large amounts thereof [25] and their described chondrogenic potential [103–107]. In a first 
preliminary study, GDF-5 (G 0.1) and insulin (I2.5) alone as well as the combination thereof 
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were added to complete chondrocyte medium in order to observe possible chondrogenic 
differentiation. In contrast to expanded chondrocytes, no synergism was found in the study 
with ASC. The highest degree of chondrogenic differentiation, when taking into account 
GAG production as an indicator for the production of cartilaginous extracellular matrix 
(ECM), could be reached by GDF-5 (Fig. 35). However, as to be expected, compared to our 
results with expanded chondrocytes, only very low GAG production was observed with ASC 
within the three weeks of culture. In order to assess the potential of GDF-5 for stem cell 
differentiation, comparison of the results with other studies, attempting to differentiate ASC 
towards a chondrogenic phenotype have to be taken into account. Feng et al. for example 
compared the extent of chondrogenic differentiation under TGF-β and GDF-5 
supplementation versus control as well as the chondrogenic differentiation induced by 
transfection with an adenoviral vector expressing GDF-5 (Ad-GDF-5). The highest degree of 
chondrogenic differentiation measured as GAG production (GAG [µg]/ DNA [µg]) was 
yielded by GDF-5 supplementation at the same concentration applied in the study presented 
here. Comparing the results in both studies, the same level of GAG production was reached 
(approximately 3.5 and 4.2 respectively) [108]. TGF-β1 was also employed for chondrogenic 
differentiation of ASC. The results in GAG production were also comparable to the degree of 
differentiation achieved here [1]. Nevertheless histological examination (Fig. 43) clearly 
revealed the great discrepancy between the obtained results and the requirements, when 
aiming at clinical application. In order to overcome the reduced capacity of ASC to 
differentiate towards a chondrogenic phenotype, media compositions are to be optimized. 
Comparing ASC and BMSC concerning their capability to differentiate towards a 
chondrogenic phenotype most of the direct comparisons found a lower chondrogenic 
differentiation capacity for ASC than for BMSC (c.f. Chapter 8). In order to distinctly 
improve the comparatively inferior chondrogenic potential of ASC, the reasons for the lower 
chondrogenic capability as well as possible optimizations of standard culture conditions were 
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investigated. For example, the application of higher concentrations of TGF-β2 in combination 
with IGF-I resulted in a cartilaginous differentiation of ASC comparable to BMSC 
differentiated by standard protocol [109]. 
Another group was able to show that in contrast to BMSC, ASC exhibited a reduced 
expression of BMP-2/-4/-6 mRNA and did not express TGF-β-receptor-I protein. 
Consequently, an increase in the concentration of TGF-β did not result in improved 
chondrogenesis. A treatment with BMP-6, however, induced TGF-β- receptor-I expression 
and in combination with TGF-β resulted in a gene expression profile in ASC similar to BMSC 
during chondrogenic differentiation [110].  
 
With regard to the main part of the presented study, i.e., the redifferentiation of expanded 
chondrocytes, it also appears desirable to further elucidate the mechanism of action involved 
in the detected synergism of GDF-5 and insulin. Viewed together with results previously 
obtained, it is remarkable that there were clear differences between the primary and the 
passaged chondrocyte cultures [88, 89]. Whereas for the primary cells, beneficial effects on 
construct size were clearly ascribable to increased proliferation, for the passaged 
chondrocytes the distinct redifferentiating effects were elicited on the cellular level 
independent of proliferation (increased ECM production per cell, shift in collagen subtype 
expression on mRNA and protein level) [88, 89]. One possible explanation for the 
redifferentiating effects on the passaged chondrocytes is an upregulation of receptor densities. 
GDF-5 transmits its signals through binding to two different serine-/threonine-kinase 
receptors forming a heterodimeric complex, that is, type II (either ActR-II, ActR-IÍB, or 
BMPR-II) and type I (BMPR-IB) [111–113]. As described for other growth factors in skeletal 
development such as TGF-β1, FGF-2, and PDGF-AB [102, 114], insulin may induce 
expression of BMPR-IB in turn enhancing the signal transduction of GDF-5. Furthermore, 
there is evidence that dedifferentiated cells pass through similar stages when redifferentiating, 
Chapter 7 – Synergistic Effects of GDF-5 & Insulin
 
 -  - 110 
as cells do in chondrogenesis [91]. Consequently, other possible mechanisms for the 
synergistic effects include transcriptional cross-talk as elicited by morphogens and growth 
factors during chondrogenesis. In our study, cross-talk between Smad and MAP kinase 
pathways activated by GDF-5 and insulin may have been involved in the observed effects 
[113, 115, 116]. The fact that GDF-5 decisively modulates the response to another cartilage-
effective protein contributes to the emerging picture of the role GDF-5 apparently plays in 
chondrogenesis and cartilage physiology. 
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Introduction 
 
Stromal cells from bone marrow and adipose tissue represent an attractive source of adult 
progenitor cells particularly for regenerative medicine in tissue engineering approaches. 
Moreover, they constitute a fascinating model system for the investigation of differentiation 
processes. The most obvious use is in the field of orthopaedics due to their proven ability to 
differentiate towards cartilage and bone. The chondrogenic potential of bone marrow-derived 
mesenchymal stem cells (BMSC) has been shown in several studies [117–125] as well as the 
osteogenic potential [121, 123, 126–129]. Due to their multilineage potential BMSC can also 
differentiate, among other lineages, towards adipocytes [123, 126, 128]. The procurement of 
bone marrow, however, is limited and associated with a procedure which may be painful and 
often demands general or spinal anaesthesia. BMSC are usually obtained from bone marrow 
aspirates by density grade centrifugation. Moreover, the cell yield is not very high thus 
demanding in vitro expansion.  
Adipose tissue constitutes another source for mesenchymal stem cells, which can be obtained 
in large quantities and under local anaesthesia [25]. Since the publication of the first work 
demonstrating the multilineage potential of stem cells derived from adipose tissue [25, 26], 
several groups have investigated the differentiation capacity of these cells. For example, their 
capability to differentiate towards a chondrogenic [103–107], osteogenic [130–132] and 
neuronal [133, 134] phenotype has been demonstrated. Several terms have been used 
synonymously for adipose-derived stem cells. For reasons of harmonization and 
simplification the International Fat Applied Technology Society agreed to employ the term 
adipose tissue-derived stem cells (ASC) for isolated, plastic-adherent multipotent cell 
population from adipose tissue [135]. According to this agreement the same nomenclature 
will be used in this article. ASC applied in the regarded studies were in brief isolated by 
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digestion of the adipose tissue with collagenase, subsequent filtration and centrifugation and 
removal of blood cells and then seeded in culture flask or dishes for further expansion.  
As mentioned above, numerous studies have shown the multilineage potential of ASC and 
BMSC. However, there is still a lively ongoing discussion among researchers in the field of 
regenerative medicine on the preferred cell type for use in specific applications. By now, there 
is a considerable number of investigations available that have directly compared ASC and 
BMSC concerning their chondrogenic, osteogenic or adipogenic differentiation capability 
under different culture conditions and with sometimes varying outcome. The aim of this 
review is to summarize and evaluate these studies in order to facilitate more rational 
conclusions on the choice of stem cells for a specific regenerative approach. Future aspects of 
research into ASC and BMSC application are discussed.  
The differentiation capacity towards a chondrogenic phenotype is of particular interest due to 
the limited availability of autologous harvestable chondrocytes for cartilage tissue engineering 
applications. 
 
Comparison of the Chondrogenic Potential of ASC and BMSC 
 
Methods to effectively differentiate mesenchymal stem cells towards a chondrogenic 
phenotype may solve one of the major problems in cartilage tissue engineering: the limited 
number of autologous, harvestable cells. As a 3-dimensional (3D) environment generally 
favours the chondrogenic phenotype, in many studies chondrogenic differentiation is 
conducted in a 3D environment. The studies directly comparing ASC and BMSC with regard 
to chondrogenic differentiation are summarized in Table 4. The extent of chondrogenic 
differentiation is evaluated by investigation of the amount of typical components of 
cartilaginous extracellular matrix (ECM), like collagen or glycosaminoglycans, which can be 
easily quantified by spectrophotometric assays. The distribution of glycosaminoglycans can 
Chapter 8 – Differentiation Capacity of ASC & BMSC in Comparison
 
 -  - 114 
be visualized by safranin O or toluidine blue staining. Synthesis of the characteristic type II 
collagen is assessed by immunohistochemical staining. But also mRNA of typical 
chondrogenic markers, like type II collagen (COL2A1), aggrecan and cartilage oligomeric 
protein (COMP), can reveal if chondrogenic differentiation was successful. Moreover, the 
expression of type X collagen, a marker for hypertrophic chondrocytes, is often analyzed. A 
high expression of type X collagen indicates a differentiation beyond the mature chondrocytes 
towards a mineralized tissue, which is generally not intended for cartilage tissue engineering 
purposes. 
 
In Vitro Studies 
Although 3D culture systems are favoured for chondrogenic differentiation, the chondrogenic 
capacity or gene expression profiles of both ASC and BMSC were assessed in monolayer (c.f. 
study by Winter [18] et al and study by Liu et al. [22]) in some investigations. Standard 
chondrogenic induction in monolayer resulted in an up-regulation of cartilage markers and 
expansion related genes. The differentiation, however, remained incomplete. A shift to the 3D 
pellet culture system in combination resulted in an improved differentiation of BMSC to a 
molecular phenotype highly resembling that of cartilage, whereas with ASC displayed a 
distinctly delayed and decreased COL2A1 expression [18]. 
In other studies, directly comparing morphology chondrogenically induced BMSC in 3D 
environment displayed round chondrocyte morphology, whereas ASC stayed small and 
fusiform [19, 136]. Pellets of ASC remained smaller in size compared to those generated from 
BMSC. Macroscopically BMSC had a higher chondrogenic potential and morphologically 
resembled chondrocytes, whereas ASC acquired a morphology resembling that of fibroblast 
[21]. 
Staining of sulfated glycosaminoglycans with safranin O or toluidine blue proved a distinct 
proteoglycan production by chondrogenically induced BMSC in 3D culture, whereas only 
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faint staining was reached in ASC cultures indicating low matrix production [19, 21, 137–
139]. 
 
Ref. Outcome Medium composition Culture 
System & 
Period 
Passage # 
ASC BMSC     
[136] ASC << 
BMSC 
DMEM/ F12, 1% insulin-transferrin-selenium (ITS), 
10-7 M dexamethasone, 50 mM ascorbate-2-
phosphate, 50 µM L-proline, 1 mM sodium pyruvate, 
5 ng/ml TGF-β2, 100 ng/ml IGF-1 
pellet; fibrin 
gel 
- 28 d 
P3 P3 
[22]  
 
 
 
 
 
DMEM, 10% FBS, 2 mM L-glutamine, 10 ng/ml 
TGF-β1, 6.25 µg/ml insulin, 50 nM ascorbate-2-
phosphate, 1% antibiotic/ antimycotic 
culture flask 
- 14 d 
(gene expr. 
profiling) 
P2 P2 
ASC << 
BMSC 
DMEM, 10% FBS, 2 mM L-glutamine, 10 ng/ml 
TGF-β3, 10-7 M dexamethasone, 50 µg/ml ascorbate-
2-phosphate, 40 µg/ml proline, 100 µg/ml pyruvate, 
50 mg/ml ITS+ premix (6.25 µg/ml insulin, 6.25 
µg/ml transferrin, 6.25 µg/ml selenious acid, 1.25 
mg/ml bovine serum albumin, 5.35 mg/ml linoleic 
acid) 
pellet culture 
- 14 d 
(comparison 
of 
chondrogenic 
potential) 
[18] ASC ≈ 
BMSC 
DMEM-HG, 10% FCS,  5 µg/ml insulin, 5 µg/ml  
transferrin, 5 µg/ml  selenious acid, 0.1 µM 
dexamethasone, 0.17 mM ascorbic acid-2-phosphate, 
1 mM sodium pyruvate,  0.35 mM proline, 1.25 
mg/ml bovine serum albumin, 10 µg/ml TGF-β3 
culture flask 
- 14 d  
 
- - 
ASC << 
BMSC 
spheroid 
culture 
- 28 d 
 
[140] ASC < 
BMSC 
DMEM, 10% FCS, 10 ng/ml TGF-β1, 6.25 µg/ml 
insulin, 1%  antibiotic/ antimycotic 
pellet culture 
- 14 d 
P3-P6 P3-P6 
[141] ASC ≈ 
BMSC 
DMEM-HG, 1% FCS, 10 ng/ml TGF-β1, 0.5 µg/ml 
insulin, 50 µM ascorbic acid 
pellet culture 
- 21 d 
P3-P5 P3-P5 
[142] ASC < 
BMSC 
DMEM-HG, 0.1 µM dexamethasone, 0.17mM 
ascorbate-2-phophate, 1% insulin-transferrin-sodium 
selenite supplement, 100 ng/ml rhBMP-2 
pellet culture 
- 21 d 
P2-P4 P2-P4 
[21] ASC << 
BMSC 
DMEM-HG, 500 ng/ml BMP-2, 10 ng/ml TGF-β3, 
10-7 M dexamethasone, 50 µg/ml ascorbate-2-
phosphate, 40 µg/ml proline, 100 µg/ml pyruvate, 50 
mg/ml, ITS+ premix 
pellet culture 
- 21 d 
P1 P1 
[143] 
 
ASC < 
BMSC 
DMEM-HG, 1% ITS+ premix, 1 mM pyruvate, 73.5 
mg/ml ascorbate-2-phosphate 
pellet culture 
- 28 d 
P1 P1 
[137] ASC < 
BMSC 
DMEM-HG, 500 ng/ml BMP-2, 10 ng/ml TGF-β3, 
10-7 M dexamethasone, 50 µg/ml ascorbate-2-
phosphate, 40 ng/ml proline, 100 ng/ml pyruvate, 
1:100 diluted ITS+ premix (6.25 µg/ml insulin, 6.25 
µg/ml transferrin, 6.25 ng/ml selenious acid, 1.25 
mg/ml bovine serum albumin, 5.35 mg/ml linoleic 
acid 
pellet culture 
- 21 d 
P2 P2 
[139] ASC < 
BMSC 
DMEM-HG, 2% FCS, 100 ng/ml BMP-2 or AdBMP-
2 (500 pfu/cell), 100 nM dexamethasone, 1xBSA/ 
linoleic acid, 1x ITS premix, 50 µg/ml ascorbate-2-
phosphate, 100 U/ml penicillin/streptomycin 
pellet culture 
- 14 d 
P2 P2 
[138] ASC << 
BMSC 
DMEM-HG, 10% FCS?,  1% antibiotic/ antifungal 
solution, 100 nM dexamethasone, 50 mg/ml 
ascorbate-2-phophate, ITS+ premix, with/ without 10 
ng/ml TGF-β3, 10 ng/ml rhBMP-6 
pellet culture 
- 21 d 
P2 P2 
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[144] ASC ≈ 
BMSC 
Complete chondrogenic differentiation medium 
(Cambrex) incl. 10 ng/ml TGF-β 
pellet culture 
- 20 d 
P1 P2 
[145] ASC << 
BMSC 
DMEM-HG, 1% ITS+, 0.1 µM dexamethasone, 37.5 
µg/ml ascorbate-2-phosphate, with/ without 10 ng/ml 
rhTGF-β1 
agarose 
hydrogels/ 
self-
assembling 
peptide 
- 21 d 
P2 P2 
[19] ASC << 
BMSC 
DMEM-HG, 4 mM proline, 50 µg/ml ascorbic acid, 
1% ITS-premix, 1mM sodium pyruvate, 0.1 µM 
dexamethasone, 10 ng/ml TGF-β3 
 P2 P2 
[146] ASC << 
BMSC 
DMEM-HG, 0.1mg/ml sodium pyruvate, 0.1mg/ml L 
– glutamine, 0.1 mg/ml pyridoxine hydrochloride, 1 
% penicillin/ streptomycin, ITS+  premix (6.25 mg/ml 
each), 10-7M dexamethasone, 10 ngTGF-β1 
 P3 P3 
[109] ASC << 
BMSC 
DMEM/F12, 1% ITS premix, 10-7 M dexamethasone, 
50 µM ascorbate-2-phosphate, 50 µM L-proline, 1 
mM sodium pyruvate  
 
ASC:  5 ng/ml TGF-β2/ 5 ng/ml TGF-β2, 100 ng/ml 
IGF-I/ 15 ng/ml TGF-β2/ 15 mg/ml TGF-β2, 300 
ng/ml IGF-I/ 25 ng/ml TGF-β2/ 25 ng/ml TGF-β2, 
500 ng/ ml IGF-I 
BMSC: 5 ng/ml TGF-β2 
 P3 P3 
[110] ASC < 
BMSC 
DMEM-HG, 5 µg/ml insulin, 5 µg/ml transferrin, 5 
ng/ml selenious acid, 100 nM dexamethasone, 0.17 
mM ascorbic acid-2-phosphate, 1 mM sodium 
pyruvate, 0.35 mM proline, 1.25 BSA, supplements: 
10 ng/ml TGF-β3, BMP-2/-4/-6/-7, IGF-I, FGFa, 
bFGF, PTHrP 
  P2-P6 P2-P6 
 
Table 4: Overview of the studies directly comparing the chondrogenic differentiation capacity of ASC and 
BMSC in vitro. 
 
In some studies the results of histological examination of matrix production and distributions 
were consistent with the results of biochemical analysis of GAG synthesis, which was 
significantly higher for treated BMSC compared to treated ASC [19], whereas another group 
found no significant difference in GAG production normalized to total DNA concentration 
[138]. 
Immunohistochemical staining of the harvested constructs revealed a type II collagen-rich 
matrix in BMSC cultures in contrast to ASC cultures, where only a faint staining [139, 146] 
or even no staining [19, 136, 138, 145] was detected. 
The results of the analysis of gene expression were consistent with the results of histological 
and immunohistochemical analysis, although there were minor differences in the results 
depending on the respective study. 
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Mehlhorn et al. compared the expression levels of chondrogenic markers expressed by 
induced ASC and BMSC on day 14. Detected chondrogenic marker expression displayed the 
superiority of BMSC to differentiate towards a chondrogenic phenotype [146]. Chondrogenic 
induction resulted in an up-regulation of type II collagen mRNA in both cell types compared 
to unstimulated cells, whereas up-regulation was significantly higher in chondrogenic BMSC 
cultures [22, 139-141]. Afizah et al found a much higher and earlier increase in type II 
collagen expression [19]. Liu et al also detected a higher increase in type II and X collagen 
expression in BMSC cultures compared to ASC cultures after chondrogenic induction, 
aggrecan expression was only detectable in BMSC culture [22]. In other studies type II 
collagen expression was only detectable in BMSC, but not in ASC [145]. Expression of type 
X collagen in BMSC cultures indicated that BMSC tend to hypertrophic chondrogenic 
differentiation, which is not intended for cartilage tissue engineering. 
Integrin-mediated signalling has emerged to play an important role in chondrogenic 
differentiation and maintenance of a chondrogenic phenotype. There were no differences 
detected in integrin expression between the two cell types [144]. 
 
In Vivo Studies 
Chondrogenic capability was also analyzed in vivo in animal models. Table 5 summarizes the 
design and the outcome of the respective studies. TGF-β1-transduced ASC and BMSC were 
injected intraarticularly and the two groups stained similarly positive for type II collagen after 
21 days [142]. Untreated ASC seeded in a collagen gel and transplanted into a full-thickness 
osteochondral defect resulted in poor cartilage matrix visualized by a faint toluidine blue 
staining, whereas the corresponding group with untreated BMSC, which displayed an intense 
blue staining [137]. ASC or BMSC, infected with adenoviral vector expressing bone 
morphogenetic protein-2 (AdBMP-2) and seeded in fibrin glue before subsequent 
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transplantation into partial thickness defects in the patellar groove, showed significant 
differences concerning adherence to the bordering walls of the defect. 
 
Ref. Outcome Animal Model Implant 
Generation 
in vivo 
culture 
period 
Passage # 
ASC BMSC 
[142] ASC ≈ BMSC immunodeficient 
mouse; injection of 
cells intra-articularly 
cells transfected 
with TGF-β1 
- 21d P2 – P4 P2 – P4 
[137] ASC << BMSC rabbit, full thickness 
osteochondral defect 
(femur) filled with 
cell/ collagen gel 
composites 
cells in collagen 
gel, α-MEM, 20% 
FBS for 1d before 
transplantation 
- 28/ 84 d P2 P2 
[139] ASC << BMSC rat, partial thickness 
defect in patellar 
groove, pellet 
transplanted into 
defect 
cells transfected 
with AdBMP-2, 
generation of cell 
pellet of infected 
& non-infected 
cells at a ratio of 
2:1 
- 14 d P2 P2 
 
Table 5:  Overview of the studies directly comparing the chondrogenic differentiation of ASC and BMSC in 
vivo. 
 
In the groups with BMSC most of the lesions were completely filled with cartilaginous repair 
tissue, whereas repair tissue deriving from ASC rarely filled the defects completely. Moreover 
AdBMP-2 infected BMSC displayed a positive toluidine blue and type II collagen staining, 
whereas AdBMP-2 infected ASC produced predominantly fibrous repair tissue lacking 
proteoglycans and being predominantly composed of type I collagen [139]. 
Although the studies in principle demonstrate the chondrogenic capacity of ASC, none of the 
studies directly comparing ASC and BMSC showed a higher chondrogenic differentiation 
capacity of ASC and only few studies showed similar outcome. Noel et al concluded that 
ASC and BMSC represent fundamentally different cell types and with different commitment 
[147]. In order to investigate into and possibly overcome the inferiority of ASC in the ability 
to differentiate towards a chondrogenic phenotype further studies were conducted. A 
successful approach by Kim and Im was to apply higher concentrations of TGF-β2 in 
combination with IGF-I. Culturing ASC under the mentioned conditions resulted in a 
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chondrogenic differentiation comparable to BMSC under standard conditions [109]. Hennig 
et al investigated the mRNA expression of several BMPs and expression of TGF-β-receptor-I-
protein to elucidate the lower chondrogenic capacity of ASC, partially contradictory to the 
findings of Kim and Im. In comparison to BMSC, ASC showed a reduced expression of 
BMP-2/-4/-6 mRNA and, in contrast to BMSC, did not express TGF-β-receptor-I protein. 
Consequently an increase in the concentration of TGF-β did not result in improved 
chondrogenesis. A treatment with BMP-6, however, induced TGF-β- receptor-I expression 
and in combination with TGF-β resulted in a gene expression profile in ASC similar to BMSC 
during chondrogenic differentiation [110]. Comparing the two studies, one has to consider 
that Kim and Im investigated the effect of higher concentrations of TGF-β, also in 
combination with IGF-I. They did not further analyze possible changes on the receptor level. 
Hennig et al, on the other hand, approached the problem by testing different growth factors 
and the combination thereof. Thereby, the expression of TGF-β-receptor-I-protein was 
analyzed. Possible positive effects of increasing the TGF-β concentrations were also 
investigated based on type II collagen synthesis. In contrast to Kim and Im, no type II 
collagen was detectable even when applying high concentrations of TGF-β in contrast to Kim 
and Im.  Kim and Im, however, did not elucidate possible impact of IGF-I on TGF-β-receptor-
I-protein and did not consider possible synergistic effects of TGF-β and IGF-I, as observed 
for growth and differentiation factor-5 (GDF-5), which also is a member of the TGF-
superfamily, and insulin, which displays great similarities to IGF-I [88]. 
 
Comparison of the Osteogenic Potential of ASC and BMSC 
 
A distinct osteogenic potential has also been demonstrated for both BMSC and ASC. In 
contrast to the studies analyzing chondrogenic differentiation, the majority of the 
investigations directly comparing osteogenic differentiation of BSMC and ASC were only 
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conducted in 2-dimensional environment (studies summarized in Table 6). Osteogenic 
differentiation is commonly evaluated by analysis of alkaline phosphatase (ALP) activity, 
matrix mineralization, which can be visualized by von Kossa staining or staining with alizarin 
S, and additionally calcium deposition assay. Another possibility to assess osteogenic 
differentiation is to analyze the expression of osteogenic markers like Runx2, osteopontin, 
osteonectin, osteocalcin and osteomodulin or alkaline phosphatase. 
 
In Vitro Studies 
After osteogenic induction in vitro (media composition given in Table 6), in some studies 
similar matrix mineralization was detected by von Kossa or alizarin S staining indicating that 
both BMSC and ASC possess osteogenic potential [18, 141, 148, 149]. In other studies the 
intensity of the staining as a measure for the amount of calcium deposition revealed, that 
BMSC had accumulated more calcium in consequence of osteogenic induction [21, 22, 136, 
150, 151]. A higher degree of matrix mineralization in BMSC cultures was also evidenced by 
stronger calcein fluorescence in matrix. Calcium quantification on day 14 as wells as on day 
28 indicated higher calcium deposition in BMSC groups than in ASC groups [152].  
 
Ref. Outcome Medium composition Culture 
Period 
Passage # 
ASC BMSC  
[136] ASC << BMSC DMEM/ F12, 1% FCS, 0.1 µM 
dexamethasone, 50 µM ascorbate-2-
phosphate, 10 mM β-glycerophosphate, 1% 
antibiotic/antimycotic 
- 21 d P3 P3 
[22] ASC << BMSC DMEM, 10% FBS, 2mM glutamine, 0.1µM 
dexamethasone, 50 µM acorbate-2-phosphate, 
10 mM β-glycerophosphate, 1% antibiotic/ 
antimycotic 
- 14 d P2 P2 
[18] ASC = BMSC MSC growth medium, 0.1 µM 
dexamethasone, 0.05 mM ascorbic acid-2-
phosphate, 10 mM β-glycerophosphate 
- 14 d - - 
[140] ASC < BMSC DMEM, 10% FBS, 10 mM β-
glycerophosphate, 0.01 µM 1,25 
dihydroxyvitamin D3, 50 µM ascorbate-2-
phosphate, 100 U/ml penicillin/ streptomycin 
- 7 d P3 & P6 P3 & P6 
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[141] ASC ≈ BMSC IMDM, 15% FCS, 0.1 µM dexamethasone, 
10mM β-glycerophosphate, 100 µM ascorbate 
- 21 d P3-P5 P3-P5 
[142] ASC < BMSC DMEM-HG, 10% FBS, 0.1 µM β-
glycerophosphate, 3mM NaH2PO4, 50 µg/ml 
ascorbic acid 
- 21 d P2-P4 P2-P4 
[21] ASC < BMSC α-MEM, 20% FBS, 100 U/ml penicillin, 100 
µg/ml streptomycin, 250 ng/ml amphotericin 
B, 10-9 M dexamethasone, 20 mM β-glycerol 
phosphate, 50 µg/ml ascorbate-2-phosphate 
14 d pre-
culture, 21 d 
osteogenic 
medium 
P1 P1 
[153] ASC ≈ BMSC  DMEM,  10% FCS, 50 µg/ml ascorbic acid, 
10 mM β-glycerophosphate 
BMP-4 transduced cells 
- 14 d P3 & P7 P3 & P7 
[152] ASC < BMSC MEM, Earle’s salts & L-Gln, 15% FBS, 1% 
antibiotics, 10 mM β-glycerophosphate, 0.28 
mM ascorbic acid-2-phosphate, 10 nM 
dexamethasone 
- 14 d - - 
[154] ASC ≈ BMSC DMEM lg, 10% FCS, 3mM L-glutamine, 100 
U/ml penicillin/ 1000 U/ml streptomycin, 100 
nM dexamethasone, 0.2 mM L-ascorbic acid-
2-phosphate, 10 mM β-glycerophosphate 
- 21 d P3-P6 P3-P6 
[149] ASC <  BMSC DMEM, 15% FBS, 0.1µM dexamethasone, 50 
µM ascorbate-2-phosphate, 10 mM β-
glycerophosphate, antibiotics (100 U/ml 
penicillin G, 100 µg/ml streptomycin) 
- 28 d P5 P3 
[155] ASC < BMSC α-MEM, 20% FCS, P/S, 2 mM glutamine, 1 
mM sodium glycerophosphate, 50µM L-
ascorbate, 10-8M dexamethasone (in most 
cases) 
- 28 d P3 P3 
[150] ASC < BMSC α-MEM, 10% FBS, 10 mM β-glycerol 
phosphate, 50 µg/ml L-ascorbic acid, 10 nM 
dexamethasone 
- 28 d P2-P3 P2-P3 
[151] ASC < BMSC DMEM-HG, 100 nM dexamethasone, 10 mM 
β-glycerophosphate, 0.05 mM ascorbic acid-2-
phosphate, 10% FBS 
- 28 d P3 P3 
[148] ASC ≈ BMSC DMEM, 10% FBS, 1% antibiotic/ 
antimycotic, 0.1 µM dexamethasone, 50 µM 
ascorbate-2-phosphate, 10 mM β-
glycerophosphate 
7 d pre-
cultivation, 21 
osteogenic 
medium 
P4 P4 
[156] - ASC: DMEM, 10% FBS, 1% antibiotic/ 
antimycotic, 0.1 µM dexamethasone, 10 mM 
β-glycerophosphate, 50 µM ascorbate-2-
phosphate 
 
BMSC: commercial osteogenic induction 
medium (Clonetics, Cambrex, BioSciences, 
Baltimore, MD): MSC growth medium, 
dexamethasone, L-glutamine, ascorbate-2-
phosphate, β-glycerophosphate, penicillin/ 
streptomycin 
- 21 d - - 
 
Table 6: Overview of the studies directly comparing the osteogenic differentiation capacity of ASC and BMSC 
in vitro.  Studies were conducted in “D with one exception - Hattori et al cultured and differentiated the cells on 
atelocollagen honeycomb-shaped scaffolds with a membrane-seal (ACHMS scaffold) [149]. 
 
ALP activity assays resulted in higher ALP activity in osteogenically induced BMSC cultures 
in comparison with corresponding ASC cultures [136, 140, 152, 155]. This is also reflected by 
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higher levels of alkaline phosphatase expression [141]. Besides ALP expressions other 
osteogenic markers were analyzed. Significantly more osteocalcin was detectable in 
differentiated BMSC cultures in comparison to the corresponding ASC cultures [152]. 
Niemeyer et al. reported increases in ALP and osteocalcin expression in both osteogenic ASC 
and BMSC cultures, without statistically significant differences between the cell types [154]. 
In another study, much higher levels of extracellular matrix genes like osteomodulin (OMD) 
were expressed by osteogenically induced BMSC compared to ASC. The same also applied 
for numerous other osteogenic markers analyzed [22].  Noel et al also found a stronger up-
regulation of osteocalcin mRNA in differentiated ASC than in differentiated BMSC cultures. 
In contrast osteogenic differentiation resulted in a higher up-regulation of osterix and alkaline 
phosphatase mRNA in BMSC cultures than in the corresponding ASC cultures [142]. 
Furthermore, osteogenic induction of BMSC and ASC was reported to result in a considerable 
down-regulation of various extracellular matrix- (ECM-) associated genes over the culture 
period. Interestingly, certain genes were only down-regulated in ASC (e.g., COL1A2, 
COL3A1), whereas expression of others were only decreased in BMSC (e.g., COL2A1, 
COL6A1) [156]. 
In a special approach, transduction of BMSC and ASC with an adenoviral vector expressing 
bone morphogenetic protein-4 (Ad-BMP-4) resulted in a stronger deposition of calcified 
extracellular matrix by ASC in comparison with BMSC at day 14. ASC cultures, however 
also simultaneously developed fat tissue.  Concerning ALP expression a tremendous increase 
was reported for both transduced BMSC and ASC, without a difference between ASC and 
BMSC cultures. On day 3, Runx2 mRNA, and on day 7 and 14, bone sialoprotein were more 
strongly up-regulated in differentiated Ad-BMP-4 transduced BMSC compared to ASC, 
whereas osteocalcin mRNA was more strongly up-regulated in differentiated Ad-BMP-4 
transduced ASC in comparison to BMSC. Cells transduced with adenovirus expressing 
enhanced green fluorescent protein (AdEGFP) and non-induced cells served as control. 
Chapter 8 – Differentiation Capacity of ASC & BMSC in Comparison
 
 -  - 123 
Neither AdEGFP transduced cells nor non-induced cells displayed any sings of osteogenic 
differentiation during the whole culture period [153]. 
 
In Vivo Studies 
The osteogenic potential of stem cells derived from bone marrow or fat tissue was also 
investigated in vivo.  The experimental design of the analyzed studies is given in table 7.  
 
Ref. Outcome Animal Model Implant Generation in vivo 
culture 
period 
Passage # 
ASC BMSC 
[153] ASC ≈ BMSC rabbit, full thickness 
defect (cranial) treated 
with AdBMP-4 
transduced cells in fibrin 
gel 
AdBMP-4 transduced cells  - 84 d  P3 & P7 P3 & P7 
[157] ASC < BMSC sheep, implantation in 
critical size defect (tibia) 
hydroxyapatite coated 
collagen scaffolds seeded 
with the cells, 1 d 
precultivation in expansion 
medium 
- 182 d P2 - P4 P2 – P4 
[149] ASC > BMSC nude mouse, s.c. 
implantation of 
osteogenic induced 
ACHMS- cell constructs 
ACHMS scaffolds seeded 
with cells, 14 days pre-
culture in osteogenic 
medium 
- 28 d P5 P3 
[152] ASC << BMSC rat, subcutaneous 
implantation 
hydroxyapatite discs 
placed in cell suspension 
overnight for cell 
attachment 
- 42 d P0 P0 
 
Table 7: Overview of the studies directly comparing the osteogenic differentiation capacity of ASC and BMSC 
in vivo. 
 
Osteogenically induced BSMC and ASC cultured for 2 weeks within atelocollagen 
honeycomb-shaped scaffolds with a membrane-seal (ACHMS) in osteogenic medium were 
transplanted s.c. in nude mice for 4 weeks. Subsequent analysis of the yielded calcification 
displayed substantial calcium and phosphate deposits at the surface. Scaffold calcification 
could be detected in osteogenically induced ASC- as well as BMSC-seeded scaffolds.  In 
contrast to the results of the in vitro study, which displayed no difference between ASC and 
BMSC seeded ACHMS scaffolds, the calcification level, however, seemed to be higher in 
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ASC cultures than in BSMC seeded scaffolds [149]. In another study hydroxyapatite (HA) 
scaffolds seeded with either BMSC or ASC were implanted after incubation for cell 
attachment. After 6 weeks histological analysis of the implants showed that more calcified 
areas in the BMSC/ HA composites than in the ASC/ HA composites, in which no bone 
formation could be detected [152].  Other approaches investigated the osteogenic capability of 
scaffolds seeded with osteogenically induced BMSC and ASC, respectively, for bone repair in 
vivo. BMSC or ASC were seeded on mineralized collagen sponges, which were implanted 
into critical size defects of sheep tibia. Significant superiority of the BSMC-group versus the 
ASC-group could be detected between week 12 and 26: in the ASC-group there was no 
significant bone formation compared to d1 at any point of time, whereas all BMSC-implants 
displayed a bridging of the defect. In this study, addition of plasma to the scaffold, when it 
was seeded with ASC elicited a positive effect and reduced the inferiority of ASC in 
osteogenic differentiation compared to BMSC [157]. Ad-BMP4-transduced MSC from bone 
and from adipose tissue were seeded in fibrin gel matrix and then implanted into full 
thickness cranial defects in rabbits. In both group, similarly substantial levels of bone 
regeneration in radiographic examination and the histological analysis were observed [153].  
 
Taken together, in general the surveyed studies, BMSC display a superiority concerning 
osteogenic differentiation. Some differences between the studies concerning the measure of 
difference in the osteogenic differentiation potential may be attributed to differences in the 
applied culture conditions and also to the kind of results on which the respective conclusion 
was based on. Particularly histological findings allow only semi - quantitative estimations. 
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Comparison of the Adipogenic Potential of ASC and BMSC  
 
As described above, also the adipogenic potential of ASC as well as of BMSC has been 
confirmed in several studies. As for osteogenic differentiation, the majority of the 
investigations the directly comparing adipogenic differentiation of BMSC and ASC were only 
conducted in 2-dimensional (2D) environment (studies summarized in table 8). Only in one 
study different scaffold materials were used to investigate the adipogenic differentiation of 
ASC and BMSC [158]. Adipogenic differentiation can be visualized by staining the lipids 
with a hydrophobic dye, e.g., red oil O. Moreover key transcription factors in adipogenesis 
like peroxisome proliferator-acitvated receptor γ (PPARγ) and C/EFBα and late markers of 
adipogenesis such as lipoprotein lipase (LPL), involved in the lipid exchange programme 
indicate adipogenic differentiation.  
 
In Vitro Studies 
In adipogenic medium ASC and BMSC both display lipid rich vacuoles stained positive with 
red oil O [18, 21, 22, 140-142, 148] indicating that stem cells from both origins are capable of 
differentiating towards the adipogenic lineage.  
 
Ref. Outcome Medium Composition Culture Period Passage # 
ASC BMSC     
[22] ASC > BMSC DMEM, 10% FCS, 0.5 mM isobutyl 
methylxanthine, 1 µM dexamethasone, 
10 µM insulin, 200 µM indomethacin, 
1% antibiotic/ antimycotic 
- 14 d P2 P2 
[18] ASC > BMSC DMEM-HG, 10% FCS,  0.01 mg/ml 
insulin, 1µM dexamethasone, 0.2 mM 
indomethacin, 0.5 mM 3-isobutyl-1-
methyl xanthine, 100 U/ml penicillin, 
100 µg/ml streptomycin 
- 14 d - - 
[140] ASC > BMSC DMEM, 10% FBS, 1 mM 
dexamethasone, 0.5 mM 3-isobutyl-1-
methyl-xanthine, 10 µg/ml  rh insulin, 
100 U/ml penicillin/ streptomycin 
- 14 d P3 & P6 P3 & P6 
 
 
Chapter 8 – Differentiation Capacity of ASC & BMSC in Comparison
 
 -  - 126 
[141] ASC ≈ BMSC IMDM (Iscove’s modified Dulbecco’s 
medium), 15% FCS, 1 µM 
dexamethasone,  5 µg/ml insulin, 60 
µM indomethacin 
- 21 d P3-P5 P3-P5 
[142] ASC ≈ BMSC DMEM/ F12, 10% FBS, 1 µM 
dexamethasone, 0.5 mM isobutyl-
methylxanthine, 60 µM indomethacin 
for 3 days, then DMEM/ F12, 10% 
FCS 
- 21 d P2-P4 P2-P4 
[21] ASC > BMSC α-MEM, 20% FBS, 100 U/ml 
penicillin, 100 µg/ml streptomycin, 250 
ng/ml amphotericin = control medium 
for 14 days, then control medium + 10-
7
 M dexamethasone, 0.5 mM isobutyl-
1-methyl xanthine, 50 µM 
indomethacin 
14 d pre- 
cultivation, 21 d 
adipogenic 
medium 
P1 P1 
[150] ASC > BMSC ITT-medium: DME/Ham’s F12, 0.05 
µM insulin, 0.2 nM 3,5,3’-
triiodthyronine, 100 nM transferrin, 17 
µM calcium panthotenate, 33 µM 
biotin, 100 nM dexamethasone 
 - 28 d P2-P3 P2-P3 
[151] ASC > BMSC DMEM-HG, 1.0 µM dexamethasone, 
0.5 mM isobutylmethylxanthine, 10µM 
insulin, 200 µM indomethacin, 10% 
FBS, 1% penicillin G/ streptomycin, 
5.0 mg/l amphotericin B 
- 28 d P3 P3 
[148] ASC ≈ BMSC DMEM, 10% FBS, 1% antibiotic/ 
antimycotic, 0.5 mM isobutyl-methyl 
xanthine, 1 µM dexamethasone, 10 µM 
insulin, 200 µM indomethacin 
7 d pre-
cultivation, 21 d 
adipogenic 
medium 
P4 P4 
[158] ASC ≈ BMSC DMEM, 10 % FCS; 0.1 mM non-
essential amino acids, 100 U/ml 
penicillin, 1000 U/ml streptomycin, 
0.2% fungizone, 0.5 mM 3-isobutyl-1-
methyl-xanthine, 1µM dexamethasone, 
5 µg/ml insulin, 50 µM indomethacin 
21 d  
cultivation on 
silk fibroin, 
collagen or 
PGA scaffolds 
in adipogenic 
medium 
P2 P2 
 
Table 8:  Overview of the studies directly comparing the adipogenic differentiation capacity of ASC and BMSC 
in vitro. 
 
The adipogenic conditions applied in various studies are given in table 9, which indicates 
great similarities concerning adipogenic media composition. Table 9 also provides a summary 
of the results comparing the differentiation potential of ASC and BMSC towards an 
adipogenic phenotype. 
Although the capability of both BMSC and ASC to differentiate towards an adipogenic 
phenotype was shown, in some studies the ratio of red stained area to the total area of the cells 
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was significantly higher in ASC than in BMSC [140, 150], or the number of donors 
displaying red oil O positive colonies was higher for ASC than for BMSC [21]. Monaco et al 
showed that the extent of lipid accumulation per differentiated cell was lower in adipogenic 
BMSC cultures than in the respective ASC culture till day 21, but became equal on day 28. 
On day 28 however the percentage of BMSC, which differentiated to adipocytes, was lower in 
BMSC cultures compared to ASC cultures [151]. Other groups stated a similar rate of red oil 
O positive colonies [141, 148]. In one study, expression of PPARγ and LPL was significantly 
higher in induced ASC than in BMSC [140] suggesting a higher potential of ASC compared 
to BMSC towards an adipogenic phenotype, whereas in another study an increase in mRNA 
encoding for PPARγ and LPL was reported for both ASC and BMSC  to a similar extent 
[142]. 
Activity of the lipogenic enzyme GPDH was found to be similarly increased in induced ASC 
and BMSC [148]. Liu et al. found genes involved in lipid metabolism like LPL, FABP4 and 
PLIN, were all also up-regulated. Among these genes, those related to energy reserve and 
cholesterol metabolism were expressed at higher levels in ASC compared to expression in 
BMSC after adipogenic differentiation [22] - Strong induction of LPL and adiponectin in 
adipogenic cultures of BMSC and ASC was also observed by Winter et al., whereby 
expression levels of LPL in ASC were significantly higher than in BMSC [18].  
Mauney et al investigated the adipogenic differentiation of ASC and BMSC in a 3-
dimensional environment. Four different porous 3D scaffold types were applied; aqueous or 
1,1,1,3,3,3-hexafluoro-2-propanol based silk fibroin scaffolds, poly(glycolic acid) (PGA) and 
collagen scaffolds. After 21 days of adipogenic culture both BMSC- and ASC- cultures 
displayed substantial amounts of lipid accumulating cells, detected by red oil O staining. In 
comparison, uninduced cultures displayed a distinctly less intense staining. Both cell types 
also showed - to a similar extent - a significant up-regulation of mRNA levels for adipogenic 
markers, such as PPARγ [158].  
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According to these results, in general ASC were shown to be superior to BMSC with regard 
to differentiation towards an adipogenic phenotype in 2D culture.   
 
In Vivo Studies 
The in vivo adipogenic differentiation of BMSC and ASC in direct comparison so far has not 
been intensively investigated. In one study, after adipogenic differentiation in vitro for 28 
days, different scaffolds seeded with BMSC or ASC were transplanted into bilateral muscle 
pouches in athymic rats (Table 9). Non-seeded scaffolds served as control constructs. After 4 
weeks in vivo, in silk fibroin constructs seeded with BMSC and ASC lipid accumulating cells 
were detected, whereby BMSC and ASC showed similar lipid accumulation [158].  
 
Ref. Outcome Animal Model Implant Generation in vivo 
culture 
period 
Passage # 
BMSC ASC 
[158] ASC ≈ 
BMSC 
muscle pouch model, rat 
(athymic, nude); 
implantation into bilateral 
muscle pouches within the 
rectus abdominus muscles 
silk fibroin, collagen or PLA 
scaffolds seeded with BMSC or 
ASC, adipogenic culture for 21 
days (c.f. Table 9) 
28 d P2 P2 
 
Table 9: Overview of the study directly comparing the adipogenic differentiation capacity of ASC and BMSC in 
vivo. 
 
Summary and Conclusions 
 
Despite the proven potential to differentiate towards the chondrogenic, osteogenic and 
adipogenic lineage, distinct differences in the extent of differentiation could be observed, 
when directly comparing ASC and BMSC. ASC turned out to be superior compared to BMSC 
concerning differentiation towards an adipogenic phenotype, whereas BSMC displayed a 
greater osteogenic and chondrogenic potential.  
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In Table 4 to 9, the outcome of each comparative study is summarized. While for all three 
lineages a clear overall trend regarding the superior cell type was obvious, there were also 
studies in which both types were similar. The differences between the cited studies may be 
attributed to different expansion levels of the cells applied as well as the application of 
different culture conditions (including growth factor supplementation). Furthermore, both cell 
populations are heterogeneous thus comprising a mixture of cells which might differ in 
differentiation capability between studies [159].   
While ASC apparently have a lower inherent potential to differentiate towards the 
chondrogenic and osteogenic lineage, applying ASC for cartilage and bone tissue engineering 
would still be of great interest due to their easier accessibility and the larger amount of 
harvestable cells. First approaches were undertaken to overcome the reduced chondrogenic 
capacity of ASC compared to BMSC. Modifications of standard differentiation protocols 
might be very promising. For this purpose, further research has to be undertaken to enlighten 
the differences of BMSC and ASC concerning signalling and receptor expression. This may 
enable to rationally enhance the differentiation potential of ASC, which would render them a 
promising alternative to BMSC. 
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Ear-shaped Cartilage Constructs (Chapter 3-5) 
 
Loss of auricular cartilage due to trauma, tumour resection or congenital defects remains a 
challenge in craniofacial surgery [1, 2]. For example, the incidence of microtia is 100 to 150 
cases per year in Germany [39]. Surgical procedures, such as costal cartilage grafts for 
reconstruction of the external part of the ear applying autologous tissue represent the state of 
the art [40]. As the cosmetic results, however, are often unsatisfactory and donor site 
morbidity as well as multiple surgical procedures are associated with this approach, tissue 
engineering is considered to be a promising alternative.  
Cartilage tissue engineering using scaffolds and chondrocytes has already been established for 
several scaffold materials [3, 14]. For auricular tissue engineering, the goal is to apply 
custom-made scaffolds for the individual patient and to seed them with autologous 
chondrocytes in order to render an aesthetic autologous implant. Rapid prototyping allows 
creation of even very complex, individual scaffolds for tissue engineering purposes [42-44].  
In the presented work, two different materials were applied for the generation of ear-shaped 
cartilage constructs (Chapter 3-5). As part of the work within the research consortium 
‘Regenerative Implants’ (Bavarian Research Foundation), the successful application of 
polycaprolactone-based polyurethane (PU) scaffolds [28] in combination with long-term 
stable fibrin gel [24] was transferred to the complex shape of the human external ear. 
Cartilage development within the construct was analyzed with spatial resolution (Chapter 3). 
Partial deficits in the generation of coherent cartilaginous tissue could be correlated to lacking 
interconnectivity of the porous scaffold structure. To optimize the ear-shaped PU scaffolds, in 
the complex shape of the external several material formulations as well as various treatment 
procedures were investigated with regard to their impact on pore size and interconnectivity 
(Chapter 4).  
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Oligo (poly (ethylene glycol)) fumarate (OPF), as a second scaffolding material, was also 
employed for the generation of ear-shaped cartilage constructs in combination with fibrin gel. 
As with the PU scaffolds, the generation of a very detailed and aesthetic ear-shaped constructs 
succeeded. Here, spatially resolved analysis demonstrated homogenous and coherent 
cartilaginous tissue in large parts of construct, indicated by intense and homogenous safranin-
O staining as well as biochemical results displaying the production of substantial amounts of 
extracellular matrix (Chapter 5).  
 
Towards Osteochondral Constructs (Chapter 6) 
 
Osteochondral defects affect the articular cartilage, but also the underlying subchondral bone 
of the joint. To date, a widely accepted treatment procedure for osteochondral defects is still 
missing [61]. Tissue engineering of osteochondral grafts has been proposed for the generation 
of individually tailored constructs of defined dimension and shape [62].  
In order to yield an optimized environment for the respective cell type, well established 
scaffold materials were chosen for the bone as well as for the cartilage component and 
combined in a single, bilayered scaffold. To engineer the cartilage-part the concept of seeding 
chondrocytes suspended in long-term stable fibrin gels in PU scaffolds [24] was chosen. For 
the bone part to be seeded with BMSC, a hydroxyapatite-based composite scaffold was 
prepared by dispense plotting, a specific rapid prototyping method. The overall goal was to 
establish a system applicable for the co-culture of cartilage and bone applying the materials 
which were already successfully applied in the project ‘Regenerative Implants’.  Here a 
seeding procedure was established which facilitated a selective seeding of the part intended 
for cartilage with chondrocytes in fibrin gel. The selectivity of the seeding procedure is a 
prerequisite for the success of the concept, as otherwise the composite part would not be left 
free for subsequent seeding with BMSC . First short-term co-culture of BMSC and bovine 
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chondrocytes evidenced the effectiveness of the method to selectively seed the respective part 
of the bilayered scaffold. Having established this system, a powerful tool for further research 
concerning optimization of co-culture conditions and the time range for pre-cultivation before 
transplantation is available. 
 
Synergistic Effects of GDF-5 and Insulin – Aspects of (Re-) Differentiation of 
Chondrocytes and ASC (Chapter 7-8) 
 
One of the major challenges in cartilage engineering is constituted by the limited number of 
harvestable autologous chondrocytes. Frequently used expansion in 2-dimensional (2D) 
environment, however, is often accompanied by rapid dedifferentiation, associated with, for 
example, predominant expression of type I collagen [60] rendering the cell less suitable for 
tissue engineering purposes [5, 74]. Growth factors have been applied either already during 
expansion of the chondrocytes [75–78] or during subsequent 3-dimensional (3D) culture [75, 
78–80] to improve the quality of the generated tissue.  
Studies conducted in the group have previously demonstrated  synergistic redifferentiating 
effects of the protein growth and differentiation factor-5 (GDF-5) and insulin particularly on 
expanded bovine chondrocytes on PGA scaffolds [88, 89]. Here, further studies were 
conducted in different 3D culture systems (fibrin gel, pellet). Besides juvenile bovine 
chondrocytes, adult human chondrocytes were also applied. The synergistic effect of GDF-5 
and insulin could also be proven in fibrin gel and pellet culture, thus, the impact can be 
considered to be independent of the chosen 3D culture system. The application of GDF-5 
alone or in combination with insulin during the expansion in 2D did not yield an enhancement 
of cartilage development in subsequent 3D culture. 
The study conducted with expanded adult human chondrocytes revealed synergistic effects of 
GDF-5 and insulin very similar to those seen for bovine juvenile cells. Redifferentiation was 
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indicated by intense safranin-O staining and tremendous up-regulation of the cartilage marker 
type II collagen as seen in the immunohistochemistry. Furthermore, this up-regulation was 
also detected on mRNA level. These results imply the possible clinical relevance of applying 
the combination of GDF-5 and insulin for redifferentiation of expanded chondrocytes and 
thus dedifferentiated autologous cells and represent an option to overcome the problem of the 
limited availability of harvestable autologous cells (Chapter 7). 
As an alternative cell source, ASC may be used for cartilage tissue engineering due to their 
multilineage potential [25, 26]. Here, a first preliminary experiment was conducted 
investigating the effects of GDF-5 and insulin on ASC were tested.  Interestingly the 
combination of GDF-5 and insulin did not exert synergistic differentiating effects on human 
ASC in contrast to expanded chondrocytes (Chapter 7).  
ASC can be obtained in large quantities and under local anaesthesia. In contrast, procurement 
of BMSC is limited and may be associated with a painful procedure. The question, which 
represents the preferred cell type for use in specific applications, is still controversially 
discussed by researchers. Reviewing the studies directly comparing the differentiation 
capacity of ASC and BMSC towards a chondrogenic, osteogenic and adipogenic phenotype 
was supposed to enable more rational conclusions (Chapter 8).  Despite the proven 
multilineage potential of both cell types, distinct differences were observed. Whereas ASC 
appeared to have a have a higher potential for adipogenic differentiation, they generally 
exhibited a lower potential to differentiate towards cartilage and bone. Nevertheless, due to 
the advantages concerning availability and procurement ASC still are an interesting cell 
source for cartilage tissue engineering. First approaches were undertaken to enlighten the 
reasons for the inferior chondrogenic capacity and to increase chondrogenic differentiation of 
ASC [110, 109]. Further research has to be conducted to elucidate the differences between 
BMCS and ASC, also concerning signalling and gene expression, in order to modify standard 
differentiation protocols to fully exploit the pote
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Appendices 
 
List of Abbreviations 
ACHMS  atelocollagen honeycomb shaped scaffolds with a membrane 
seal 
ActR activin receptor 
AdBMP adenovirus expressing bone morphogenetic protein 
AdEGFP adenovirus expressing enhanced green fluorescent protein 
ALP alkaline phophatase 
ANOVA analysis of variance 
ASC adipose tissue-derived stem cells 
BMP bone morphogenetic protein 
BMPR bone morphogenetic protein receptor 
BMSC bone marrow derived stem cells 
CAD computer aided design 
CAM computer aided manufacture 
CDHA calcium-deficient hydroxyapatite 
CCM complete chondrocyte medium 
CDMP-1 cartilage derived morphogenetic protein-1 (GDF-5) 
COL collagen (gene) 
CT computer tomography 
d day 
2D/ 3D 2-dimensional/ 3-dimensional 
p-DAB p-dimethylaminobenzaldehyde 
DAPI 2-(4-amidinophenyl)-1H-indole-6-carboxamide 
DBM  demineralized bone matrix 
Appendices
 
 -  - 162 
DMEM Dulbecco’s Modified Eagle’s Medium 
DNA deoxyribonucleic acid 
ECM extracellular matrix 
EDTA ethylenediammintetraacetic acid 
EGF epidermal growth factor 
FABP4 fatty acid binding protein-4 
FDA Food and Drug Administration 
FGF fibroblast growth factor 
bFGF basic fibroblast growth factor 
GAG sulphated glycosaminoglycans 
GAPDH glyceraldehydes-3-phosphate dehydrogenase (GPDH) 
GDF-5 growth and differentiation factor-5 (CDMP-1) 
HuGDF-5 recombinant human growth and differentiation factor-5 
GFP green fluorescent protein 
GPDH glyceraldehyde-3-phosphate dehydrogenase  
HA hydroxyapatite 
H & E haematoxylin & eosin 
HEPES N-2-hydroxyethylpiperazine-N’-2-ethansulfonic acid 
IGF-I insulin-like growth factor-I 
ITS insulin, transferring, selenious acid 
LPL lipoprotein lipase 
MCH  polymer by polymerization of polycaprolactone-diol on 
mannitol, transformation with hexamethyldiisocyanate 
MCI   polymer by polymerization of polycaprolactone-diol on 
mannitol, transformation with polyisophorondiisocyanate 
mio million 
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MSC mesenchymal stem cells 
MVI polymer by polymerization of polyvalerolactone on mannitol; 
 transformation with polyisophoronodissocyanate 
NEAA non-essential amino acids 
OPF oligo (poly (ethylene glycol) fumarate 
P passage 
PBS phosphate buffered saline 
PCL poly (ε-caprolactone) 
PDGF platelet-derived growth factor 
PGA poly (glycolic acid) 
P-4HB poly (4-hydroxybutyrate) 
PLA poly (lactic acid) 
PLLA poly (L-lactic acid) 
PLGA poly (lactic-co-glycolic acid) 
PLIN perilipin 
PPARγ peroxisome proliferator activated receptor γ 
PU polyurethane 
RNA ribonucleic acid 
mRNA messenger ribonucleic acid 
rpm rounds per minute 
RT reverse transcription 
Runx2 runt-related transcription factor-2 
SD standard deviation 
SEM scanning electron microscopy 
β-TCP tricalcium phosphate 
T-75 culture flask 75 cm2 cell culture flask  
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T-150 culture flask 150 cm2 cell culture flask 
VEGF  vascular endothelial growth factor 
WW wet weight 
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